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ABSTRACT 
Histatins are a group of histidine-rich antimicrobial proteins present 
in human salivary secretions. Previous studies have shown that histatins 
play an important role in the maintenance of enamel integrity and defense 
against oral bacteria and fungal pathogens in the oral cavity. Because 
histatins differ in their ability to inhibit blastopore viability and germ tube 
formation, it is important to be able to quantitatively determine individual 
histatin concentrations. Such determinations would be essential for 
understanding and comparing the antibacterial activities of the saliva in 
healthy and diseased persons, and in finding a relation between individual 
histatin concentration and function. 
The present study is focused on determination of the physiological 
concentration of the major histatins 1, 3, and 5 in glandular secretions and 
whole saliva in order to evaluate the relationship of individual histatin 
concentrations to their functional capacity in the oral cavity. Human parotid 
and submandibular / sublingual secretions were collected from 19 healthy 
donors in the presence and absence of gustatocy stimulation. Whole saliva 
was collected from the same group of donors with masticatocy stimulation. 
A cationic polyaccylamide gel electrophoresis system (cationic PAGE) was 
used in combination with scanning densitometcy to measure the 
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concentrations of histatin 1, histatin 3, and histatin 5. In addition, total 
histatin concentrations were measured by an indirect enzyme-linked 
irnmuno-sorbent assay (ELISA) using both affinity purified rabbit and goat 
anti-histatin 1 antibody preparations. In parotid secretion, the results 
showed that the concentration of histatin 1 ranged from 1.30-9.49 mg<>/o, the 
concentration of histatin 3 ranged from 0.56-12.0 mg<>/o, and the 
concentration of histatin 5 ranged from 0.87-21.8 mg<>/o. In 
su bmandibular / su blingual secretions, the corresponding concentration 
ranges were 0.91-16.1 mg% for histatin 1, 0.20-13.88 mg<>/o for histatin 3, 
and 0.31-17.8 mg<>/o for histatin 5. The histatin concentration in stimulated 
whole saliva ranged from 0.84-2.73 mg% for histatin 1, 0.26-2.25 mg% for 
histatin 3, and 0.21-4.33 mg% for histatin 5. These values tended to be 
lower than the concentration of histatins in parotid and 
su bmandibular / su blingual secretions. 
Total histatin concentrations estimated by ELISA with antibodies 
against histatin 1 were lower than the sum of histatin 1, 3, and 5 
determined from densitometric analysis. This discrepancy was shown to 
depend in part on differences in the avidity of the histatin 1 antibody for 
histatin 3 and 5 and presumably on partial masking of epitopes on histatin 
molecules due to complexing with other salivary proteins. ELISA 
measurements of total histatins in glandular secretions were statistically 
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higher under stimulated conditions than under unstimulated conditions. 
The total histatin in stimulated submandibular/sublingual secretion was 
greater than that in stimulated parotid secretion. In addition, inter-
individual variations of salivary histatin concentrations of healthy subjects 
were relatively broad. It is significant that the mean concentration of 
histatins in glandular secretions as well as in some samples of whole saliva 
determined either densitometrically or by ELISA were equal to, or greater 
than, histatin concentrations required to elicit antimicrobial action in vitro. 
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Figure 1: Major histatins in human salivary glandular secretions and in 
whole saliva supernatant. (A) Amino acid sequences of histatin 1, 3, 
and 5. Histatin 1 is encoded in the HIS 1 gene, histatin 3 is encoded 
in the HIS2 gene and histatin 5 is a proteolytic fragment of histatin 
3. (B) Comparison of protein profiles by cationic PAGE of parotid, 
submandibular/sublingual, and whole saliva supernatant under 
stimulated (S) and unstimulated (US) conditions. Each lane 
contains the equivalent of 128 µl of the original sample. 
Figure 2: Relative avidity of goat anti-histatin 1 antibody for salivary 
histatins. 
Figure 3: Total histatin concentrations m parotid secretion, 
submandibular/sublingual secretion and whole saliva under 
stimulated and unstimulated conditions determined by 
densitometric analysis (solid bar) and ELISA (hatched bar). The 
ELISA values were corrected for differential avidity of the histatin 
1 antibody for histatin 3 and histatin 5. Abbreviations: PS, parotid 
stimulated; PU, parotid unstimulated; SS, submandibular/ 
sublingual stimulated; SU, submandibular/sublingual unstimu-
lated; and WS, whole saliva. 
Figure 4: Comparison of total protein output (solid bar) with total histatin 
output (hatched bar) from both pairs of parotid and 
submandibular/sublingual glands. Numbers over the bars 
represent output values (mg/min) under stimulated and 
unstimulated conditions. Output (mg/min) = Flow Rate (ml/min) x 
Concentration (mg/ml). 
Figure 5: Survival of exogenous histatin added to whole saliva supernatant. 
For control, histatin 3 was incubated at 20°C (bar 1) or 100°C (bar 
2) for 3 min, filtered and quantitated by HPLC. For experimental 
samples, histatin 3 was added to boiled WS and incubated at 37°C 
for O min (bar 3) or 20 min (bar 4). Histatin 3 was also added to 
non-boiled WS and incubated at 37°C for O min (bar 5), 1 min (bar 
6), 5 min (bar 7), and 20 min (bar 8). 
Figure 6: The relationship between the effect of flow rate and duration of 
stimulation on the protein concentration in human parotid 
secretion (A) and submandibular/sublingual secretion (B). Adapted 
from the data of Dawes [1969 and 1971]. 
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INTRODUCTION 
Saliva is a complex biological fluid derived in large part from parotid 
and su bmandibular / su blingual gland secretions, with minor contributions 
from minor salivary glands and gingival crevicular fluid. Saliva is known to 
exhibit a multipotential antibacterial role through a variety of mechanisms, 
many of which involve salivary proteins. The first level of defense against 
microorganisms is purely mechanical provided by a continuous salivary flow 
along with saliva-induced bacterial agglutination. A specific, sophisticated 
second level of defense is the immune system and its components. In the 
oral environment the major immunoglobulin is secretory immunoglobulin A 
(slgA). However, there are small amounts of IgG, IgD, IgM, and IgE that enter 
the oral cavity in gingival crevicular fluid [Mandel et al., 1979]. A third level 
of defense involves a number of host derived antimicrobial proteins that 
form the so-called "non-immune oral host defense system." One of these 
proteins is lysozyme, an enzyme capable of killing many gram-positive 
bacteria by cell wall lysis [Pollock et al., 1979]. Another protein is 
lactoperoxidase, an enzyme which converts thiocyanate into 
hypothiocyanate ion (OSCN-) which can oxidize sulfhydryl groups in 
bacterial proteins resulting in inhibition of respiration [Thomas and Aune, 
1978]. Yet another protein is lactoferrin, an iron binding protein that 
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sequesters ferric ion which is an essential nutrient for growth of oral 
microorganisms [Masson and Heremans, 1966]. 
Human parotid and submandibular secretions contain at least 40 
electrophoretically distinct proteins, and most of these have been isolated 
and characterized [Minaguchi and Bennick, 1989; Lamkin and Oppenheim, 
1993; Scannapieco, 1994]. Histatins have been shown to comprise a family 
of proteins present in salivary secretions of both humans and subhuman 
primates [Xu et al., 1990; Xu and Oppenheim, 1993]. Histatins are small 
proteins found in both parotid and su bmandibular secretions [ Oppenheim 
et al., 1986, 1988; Troxler et al., 1990). Electrophoretic analysis of parotid 
secretion in a cationic PAGE system revealed that histatins separate into 
three major protein pairs representing histatin 1 and 2, histatin 3 and 4, 
and histatin 5 and 6 [Oppenheim et al., 1988). In addition, a number of 
more cathodically migrating bands in the cationic PAGE system correspond 
to histatins 7-12 [Troxler et al., 1990]. Histatin 1, histatin 3, and histatin 5 
are the major histatins representing approximately 70-80% of the histatin 
family, and primary sequence data has shown that histatin 1, histatin 3, 
and histatin 5 contain 38, 32, and 24 amino acid residues, respectively 
[Oppenheim et al., 1988). The molecular weight of histatin 1, 3, and 5 are 
4,929, 4,063, and 3,037, respectively. Each of the major histatins contains 
seven histidine residues, and histatin 1 contains 1 mol of phosphate/mo! of 
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protein due to a phosphmylated serine at residue 2. Histatin 1 and histatin 
3 are derived from different structural genes, while histatin 5 is a proteolytic 
product of histatin 3 [Oppenheim et al., 1988; Xu and Oppenheim, 1993; 
Sabatini et al., 1993]. Histatin genes have been localized to human 
chromosome 4q12 [vanderSpek et al., 1989]. The gene for histatin 1 is called 
HISl and the gene for histatin 3 is called HIS2. These genes are separated 
by approximately 13 kb [Sabatini et al., 1989]. HISl spans 8.5 kb and 
contains 6 exons and 5 intrans, exons 2-5 of HIS2 span 5.5 kb and HISl 
and HIS2 exhibit 89% nucleotide sequence homology. The overall gene 
structure of HISl and STATH [the gene for statherin) is nearly identical and 
it is interesting that the nucleotide sequence of these genes is 77-81 % 
identical for intrans and 80-88% identical in the exon encoding the 5' 
untranslated region [Sabatini et al., 1993]. This provides strong evidence 
that these genes resulted from a duplication event in an extant progenitor 
gene. 
Histatins, praline-rich proteins [PRPs), cystatins, and statherin have 
all been implicated as precursors of the proteinaceous film covering tooth 
surfaces called "acquired enamel pellicle" because they have a high affinity 
for hydroxyapatite [Hay, 1973; Hay et al., 1979]. These proteins have also 
been shown to inhibit primary and secondary calcium phosphate 
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precipitation suggesting a role in maintenance of enamel surfaces [Gron and 
Hay 1978; Hay 1987; Oppenheim et al., 1988]. 
However, histatins play an additional biological role in the nonimmune 
defense system by exhibiting antimicrobial properties. These include 
agglutination of the periodontal pathogen, Porphyrorrwnas gi,ngivalis 
[Murakami et al., 1990], inhibition of a protease secreted by P. gi,ngivalis 
[N ishikata et al., 1991] and bactericidal and bacteriostatic effects against 
several strains of the mutans group of Streptococci [McKay et al., 1984; Xu 
and Oppenheim 1990]. The concentration of the major histatins in salivary 
secretions appears to be well in the range of the LDso for the bacteriocidal 
effects of histatins on all these microorganisms. His ta tin 5, the smallest of 
the major histatins, is most effective, and histatin 1, the largest of the major 
histatins, is least effective as an antimicrobial agent. Histatins also exhibit 
antifungal effects which have been studied specifically with respect to the 
pathogenic yeast, Candida albicans [Pollock et al., 1984; Oppenheim et al., 
1986, 1988; Xu et al., 1991]. It is interesting to note that the presumed 
concentrations of histatins in salivary secretions are also within the range of 
LDso and IDso values for the anticandidal properties of histatins. 
Because histatins differ in their ability to inhibit blastopore viability 
and germ tube formation, it is important to be able to determine 
quantitatively individual histatin concentrations. Such determinations 
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would be essential for understanding and comparing the antibacterial 
activities of the saliva in healthy and diseased persons and in 
understanding the relationship between individual histatin concentrations 
and their biological function. 
The concentration of histatins has been investigated in several clinical 
studies on AIDS patients. Histatins were measured immunologically 
[Atkinson et al., 1990] by rocket electrophoresis [Mandel et al., 1992] and by 
capillary electrophoresis [Lal et al., 1992a]. Contradictory results were 
obtained from these studies regarding the histatin concentrations in control 
subjects and in HN positive individuals. A possible explanation for these 
discrepancies could be that different analytical tools were used to measure 
histatins, pointing to the need for development of an accurate and reliable 
procedure for measuring the concentration of histatins in oral fluids. 
The purpose of this investigation was to determine quantitatively the 
physiological concentrations of both total and individual histatins in human 
glandular secretions and in whole saliva under both stimulated and 
unstimulated conditions. This has been accomplished by the development of 
both a densitometric procedure and an immunological assay (ELISA) for 
histatin quantification in order to gain a better understanding of the rate of 
histatin production in response to a given stimulus as well as the survival 
and clearance of histatins from the oral cavity. 
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LITERATURE REVIEW 
SALIVA 
Composition and function 
Saliva has manifold functions in protecting the integrity of the oral 
mucosa: it participates in clearing the oral cavity of food residues, debris 
and bacteria; it acts as a buffer because it contains bicarbonate and 
phosphate ions which modulate the deleterious effects of organic acids and 
bases produced by oral bacteria; it provides calcium and phosphate ions 
needed for remineralization of enamel surfaces; and due to the presence of 
certain salivary proteins, it has antibacterial, antifungal, and antiviral 
capacity. 
Saliva is a complex biological fluid that probably plays the most 
important role for maintaining the integrity of the oral cavity [Mandel, 1986; 
Grahn et al., 1988). Whole saliva is a mixed oral fluid derived primarily from 
secretions of the major salivary glands (parotid and 
su bmandibular / su blingual) and to a lesser extent from the minor salivary 
glands. In addition, whole saliva contains a number of constituents of non-
salivary origin including gingival crevicular fluid, bacteria, bacterial 
products, blood cells such as polymorphonuclear leucocytes, serum, 
desquamated epithelial cells and cellular components, viruses and fungi, 
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food debris, and expectorated bronchial secretions. Saliva is composed of 
99% water with the remaining one percent consisting for the most part of 
proteins, lipids, and small organic molecules such as glucose and urea as 
well as electrolytes, the most abundant of which are sodium, calcium, 
chloride, and phosphates. Most of the organic molecules are produced by 
the acinar cells, some are synthesized in ductal cells, and some enter the 
oral cavity via gingival crevicular fluid and serum. The major proteins of the 
salivary glands are produced by acinar cells, and many of these are 
members of protein families. Each family has a number of distinct but 
closely related members that display genetic polymorphisms. These families 
include the PRPs with at least 13 different members, the histatins 
(histidine-rich proteins) with at least 12 different members, the salivary 
cystatins (cysteine-containing proteins) with at least 3 different members, 
and the statherins (tyrosine-rich proteins) with at least 2 different members. 
In addition, saliva contains mucins of high (MG 1) and low molecular weight 
(MG2), glycosylated and non-glycosylated forms of amylase, and several 
salivary peroxidases. Salivary proteins not present as families are epidermal 
growth factor, lysozyme, lactoferrin, and albumin. The function of some of 
these proteins has been relatively well-characterized although the function 
of others in the oral cavity remains to be elucidated. The majority of salivary 
proteins are the secretory products of one or more of three different pairs of 
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salivary glands: the parotid, the submandibular, and the sublingual glands. 
The secretoiy apparatus in these glands has an enormous capacity to 
produce proteins, and the total protein concentration is affected by the 
volume of fluid secreted per unit time. The rates of synthesis and 
degradation of secreted proteins can drastically alter both the concentration 
of total protein and the composition of proteins in saliva. Salivary gland 
dysfunction can result in either increased or decreased quantities of 
glandular secretions. Clinically, disorders resulting in decreased saliva 
production are the most common and lead to xerostomia (dt.y mouth) which 
invariably results in an increased incidence of oral disease [Levine, 1987]. 
Salivary gland hypofunction, such as that which occurs in Sjogren's 
syndrome [Fox et al., 1985] following therapeutic irradiation to treat head 
and neck cancer (Leveque et al., 1993] and in dysfunction of the immune 
system [Schi0dt et al., 1992], leads to a reduction of salivary flow. 
Regardless of the etiology, xerostomia results in deterioration of the mucous 
membranes of the mouth and the throat, destruction of teeth by erosion and 
caries, and in some instances, severe life-threatening infections [Brandtzaeg 
1983; Ganguly et al., 1986; Mandel and Ellison 1985; Tenovuo et al., 1987]. 
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Protein concentration 
There have been numerous reports on the protein concentration of 
salivazy secretions and whole saliva under various physiological conditions. 
However, there are relatively few studies in which the protein concentration 
has been measured both colorimetrically and immunologically in parotid 
secretion, submandibular/sublingual secretion, and whole saliva, in a 
statistically adequate group of subjects. The information available on protein 
concentrations from various studies is summarized in Table 1. It is difficult 
to compare the results of these investigations because of variability in 
collection procedures (e.g., time of collection, flow rate, type of stimulation); 
sample handling (e.g., freezing and thawing, lyophilization, dialysis); and 
method of quantitation (e.g., colorimetric method, protein standard, amino 
acid analysis). Despite differences in methods, a general picture emerges as 
to protein concentrations in these studies. 
First, there is a great variation in the concentration of total protein 
in glandular secretions among individuals with or without stimulation. 
Second, the protein concentration in parotid secretion declines briefly after 
the onset of stimulation but increases continuously with the duration of 
stimulation [Dawes, 1969]. Third, under conditions of continuous 
stimulation, as the flow rate increases so does the protein concentration 
[Dawes, 1971]. Fourth, both the ranges and absolute values of protein 
concentrations are increased when stimulation is applied, but the extent of 
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Table 1: Total protein concentration in glandular secretions under stimulated (S) 
and unstimulated (US) conditions. 
Gland s us 
Parotid + 
Parotid + 
+ 
Parotid + 
Parotid + 
Submandibular + 
+ 
Technique Concentration* 
Lowry procedure (casein) 232 ± 128 
Lowry procedure 889 ± 181 
Lowry procedure 446 ± 46 
Rocket electrophoresis 142 (71-401) 
142 (75-206) 
163 (81-407) 
Spectrophotometry 52 ± 37.6 
Lowry procedure (casein) 96 ± 40 
Lowry procedure (casein) 147 ± 64 
239 ± 130 
344 ± 132 
* Concentration are expressed in mg% 
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Reference 
Dawes [1969] 
Dawes [1981] 
Dawes [1981] 
Mandel et al. [1992] 
Streckfus et al. [1994] 
Dawes [1971] 
the increase depends on the nature of the stimulus (e.g., gustatory versus 
masticatory). Finally, different techniques were used for protein quantitation 
making it difficult in some cases to compare results from one investigation 
with those from another. 
Flow rate 
Flow rate and buffer capacity of saliva are among the most important 
physical parameters for providing initial protection of the oral cavity. The 
main factor affecting the composition of saliva is the salivary flow rate. A 
decrease in salivary flow rate has been related to changes in buff er capacity, 
a reduction in the concentration of components of both the immune and 
non-immune defense system, and changes in the composition of bacterial 
plaque and the progression of caries [Bratthal and Carlsson, 1986]. There is 
general agreement as to the range of flow rates of the major salivary glands 
and whole saliva in humans under stimulated and unstimulated conditions 
(Table 2). Several large studies have been conducted to determine 
stimulated and unstimulated salivary flow rates in healthy individuals 
[Andersson et al., 1974; Heintze et al., 1983]. The average stimulated and 
unstimulated flow rate of whole saliva is approximately 4 ml/min and 0.3 
ml/min, respectively. It has been shown that parotid gland flow rates are 
not affected by the aging process in healthy individuals [Baum, 1981; 
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Table 2: Flow rate in glandular secretion and whole saliva. 
Saliva Unstimulated Flow rate* Reference 
Whole Saliva 0.39 Andersson et al. [1974] 
0.32 Becks and Wainwright [1943] 
0.26 - 0.36 Heintze et al. (1983] 
0.32 Shannon and Frome (1973] 
Parotid 0.08 Shannon et al. (1967] 
0.172 Atkinson et al. (1990) 
Submandibular 0.2 Enfors et al. [1962) 
0.2 Atkinson et al. (1990) 
0.26 Dawes (1971] 
0.08 - 0.8 Tylenda & Baum (1988) 
Saliva Stimulus Flow rate* Reference 
Whole Saliva Paraffin wax 0.52 - 1.23 Andersson et al. [1974] 
1.92 - 2.24 Crossner et al. [1984) 
4.05 - 4.55 Heintze et al. [1983] 
1.69 Shannon and Frome [1973] 
Parotid Lemon 3.0 - 3.26 Mason and Chisholm [1975] 
Juice 2.72 
Grape-flavored candy 2.02 Shannon et al. [197 4] 
2% Citric acid 1.04-1.60 Mandel et al. (1992] 
2% Citric acid 0.86 Atkinson et al. [1990] 
Submandibular 1 % Citric acid 1.58 Ericson et al. (1972] 
2% Citric acid 0.78 Atkinson et al. (1990) 
• Flow rate is expressed as ml/min/2 glands. Where a range is given the values are the mean flow rates 
from several measurements conducted on different groups of subjects. 
12 
Chauncey et al., 1981; Gandara et al., 1985]. In contrast, stimulated 
su bmandibular gland flow rates have been shown to be higher in healthy 
young individuals than in healthy elderly individuals [Ava et al., 1995]. 
HUMAN SALIVARY HISTATINS 
Discovery, isolation, and chemical structure 
The discovery of human salivary histatins was the result of a cascade 
of events that began almost two decades ago. Several groups of investigators 
have conducted studies on histidine-rich proteins in salivary secretions. 
This has led to a confusing nomenclature for these proteins. The discussion 
below will present a description of studies on histatins chronologically. For 
clarity, the different names applied to histatins by different investigators are 
summarized in Table 3. 
Bonilla and Stringham [ 1969) were probably the first to describe the 
isolation of basic polypeptides from parotid secretion by gel filtration 
chromatography on a highly cross-linked polyacrylamide resin called Bio-
Gel P-2. A group of proteins that absorbed to the resin could be eluted with 
1.0 M sodium chloride, and these proteins were shown to be the most basic 
protein components in parotid secretion as evidenced by their 
electrophoretic mobility at pH 2.9 in an acidic 6 M urea polyacrylamide gel 
system. Surprisingly, the basic proteins retained on Bio-Gel P-2 migrated in 
this cationic PAGE system much faster than lysozyme which at the time was 
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Table 3: Nomenclature for salivary histidine-rich proteins used by different 
investigators. 
Peters and Azen 
1972 
Pbf 
Pbe 
Pbd 
Pba,Pbb 
Hay 
1975 
Component 11 
Baum et al. 
1977 
HRP 1 
HRP2 
HRP3 
HRP4 
HRPS 
HRP6 
HRP7 
14 
Oppenheim et al. 
1988 
Histatin 1 
Histatin 2 
Histatin 3 
Histatin 4 
Histatin 5 
Histatin 6 
Histatin 7 
Sugiyama et al. 
1990 
81 
C1 
D2 
considered to be the most basic protein in parotid secretion. 
Several years later, Azen [ 1972] identified a group of low molecular 
weight, basic salivary proteins, that were named "parotid basic proteins" 
(Pbs). Based on the electrophoretic migration of Pbs from different 
individuals in an acid-urea starch gel system, two loci were identified, Pbl 
and Pb2. The basic proteins encoded in the Pbl locus were called Pba, Pbb, 
Pbd, and Pbe, and the basic protein encoded in the Pb2 locus was called Pbc 
[Azen, 1972]. Subsequently, Azen [1973] identified similar basic proteins in 
parotid secretion from the subhuman primates, Macaca mulatta and Macaca 
nemistrina. At about the same time, Balekjian and Longton [ 1973] partially 
purified three basic proteins from human parotid secretion by ion exchange 
chromatography on Bio-Rex 70 and erroneously referred to these proteins 
as histones. For each of the three proteins, basic amino acids constituted 
35-65% of the total amino acids and the mol% of histidine was 17 .8, 25.4, 
and 31. 9, respectively. 
Hay [ 1973] showed that certain salivary proteins selectively adsorbed 
to hydroxyapatite and suggested that these proteins may bind to tooth 
surfaces in vivo. Stimulated and unstimulated parotid secretion was 
incubated with hydroxyapatite, and selectively absorbed proteins were 
recovered and chromatographed on Sephadex G-50. Electrophoretic 
analysis of column fractions showed that there were seven distinct proteins 
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in parotid secretions that bound to hydroxyapatite. Four of these 
components have been shown to be PRPs (i.e., PRP 1, PRP 2, PRP 3, PRP 4) 
and are characterized by high levels of praline (22-27%), glycine (20-22%), 
and dicarboxylic amino acids (26-36%), particularly glutamate [Oppenheim 
et al., 1971]. Examination of PRPs in the analytical ultracentrifuge indicated 
that they have molecular weights of approximately 12,300 (PRP 1 + 2) or 
6,100 (PRP 3 + 4). Hay [1973, 1975] described two additional proteins that 
selectively adsorbed to hydroxyapatite and named these proteins 
"Component I" and "Component II." These acidic peptides had unusual 
amino acid compositions with calculated minimum molecular weights of 
approximately 5,000 based on amino acid analysis. Component I had the 
highest affinity for hydroxyapatite and enamel powder and had a high 
glutamate and tyrosine composition. Component II had a somewhat lower 
affinity for hydroxyapatite and had high aspartate and histidine 
compositions. Finally, a seventh component (Component VII) was observed 
and was shown to be comprised of three or more proteins related to PRPs. 
Hay [ 1975] described the partial characterization of a protein named 
"histidine-rich component II" from human parotid saliva. Isolation was 
performed by anion exchange chromatography on a DEAE Sephadex A-25 
column. The electrophoretic behavior of Component II was similar to that of 
an acidic protein because it migrated to the midsection of an anionic PAGE 
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gel at pH 8.3. However, the amino acid composition of Component II showed 
that it was not an acidic protein at all because it had a calculated isoelectric 
point of 7.04. Component II had a remarkably high content of histidine (19 
mol%), arginine ( 11 mol%) and dicarboxylic amino acids (23 mol%). 
Component II exhibited high affinity for hydroxyapatite and dental enamel 
surfaces, suggesting a possible role in the early stages of the formation of 
the acquired enamel pellicle. 
The amino acid composition of Component II was very similar to that 
of the partially purified basic histidine-rich proteins described later by 
Baum et al. [1976) and Peters and Azen [1977). Baum et al. [1976) isolated 
a group of five cationic histidine-rich proteins in parotid saliva and called 
these proteins HRP 1, HRP 2, HRP 3, HRP 4, and HRP 5. Whole saliva 
contained primarily HRP 5 with traces of HRP 1. Isolation and partial 
purification of HRP 1 was performed using a four-step chromatographic 
procedure and polyacrylamide gel electrophoresis. HRP 1 had a calculated 
isoelectric point of 7.0 based on amino acid composition, a histidine 
composition of 17 mol% and a minimum molecular weight of 5,733. Baum 
et al. [1976] proposed that HRP 1 could be the precursor of the other HRPs 
found in parotid secretion. In addition, it was postulated that degradation of 
HRP 1 could give rise to the smaller and more basic HRP 3 and HRP 5. 
Electrophoretic analysis showed that the migration patterns of HRP 5 and 
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both Pba and Pbb were identical as were the migration patterns of HRP 4 
and Pbd, and of HRP 3 and Pbe. In contrast, the electrophoretic migration 
pattern of Pbc was not similar to any of the HRPs. Although HRP 1 and HRP 
2 were not originally obseived as electrophoretic entities by Azen [1972) it 
was shown later that HRP 1 may be synonymous with Pbf [Baum et al., 
1976]. 
Baum et al. [1977a] described a cationic PAGE system that gave 
much better resolution of basic proteins such as HRPs. This enabled 
further separation of the HRP 5 band into three components designated 
HRP 5, HRP 6, and HRP 7. Thus, the basic HRPs in parotid secretion were 
shown to consist of a group of at least seven components. Specifically, when 
parotid secretion was examined in the cationic PAGE system, HRPs were 
separated into three pairs of bands consisting of HRP 1 and HRP 2, HRP 3 
and HRP 4, HRP 5 and HRP 6, and a more cathodically migrating band 
corresponding to HRP 7. Thus, the cationic PAGE system proved to be a 
important analytical tool in later studies where HRPs were isolated to 
homogeneity and completely characterized. Baum et al. [ 1977b] isolated 
HRPs and nuclear histones from parotid glands of the subhuman primate, 
Macaca mulatta, and showed that these proteins were not related to one 
another on the basis of electrophoretic mobility in the cationic PAGE system 
or amino acid composition. 
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Peters and Azen [ 1977] isolated and partially characterized several 
basic Pb proteins from human parotid secretion by acid-urea starch gel 
electrophoresis and gel filtration chromatography on Bio-Gel P-10. These 
basic proteins contained approximately 45% histidine + arginine + lysine 
and all had isoelectric points above 9.5. Based on SDS-PAGE, the molecular 
weight of Pbd and Pbe was 7,200, the molecular weight of Pba and Pbb was 
5,800 and the molecular weight of Pbc was 6,100. In addition, the histidine 
content of Pba and Pbb was 26 mol%, 21 mol% for Pbd and Pbe, and 22.5 
mol% for Pbc. All of the Pb proteins lacked cysteine, praline, threonine, 
valine, and methionine. 
Amino acid analysis indicated that the Pb proteins were similar to the 
HRPs isolated by Baum et al. [ 1976]. According to cathodic migration of 
these proteins, Baum et al. [1976, 1977a] named them HRP 1 to HRP 7, 
which after electrophoresis appeared as three pairs of double bands (HRP 1 
+ 2, HRP 3 + 4, HRP 5 + 6) with a seventh band (HRP 7) which migrated 
most rapidly at the buffer front. Despite the somewhat confusing 
nomenclature used for histidine-rich proteins in parotid secretion, the best 
evidence indicates that HRP 1 and HRP 2 correspond to Pbf, HRP 3 
corresponds to Pbe, HRP 4 corresponds to Pbd, and HRP 5 and HRP 6 
correspond to Pba and Pbb. The histidine-rich acidic peptide referred to as 
Component II by Hay [ 1975) was considered to be a different protein due to 
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its affinity for hydroxyapatite, electrophoretic, and chromatographic 
behavior and pl close to neutrality. Component II was subsequently shown 
to be HRP 1 ( see below). 
MacKay et al. [1984] isolated milligram quantities of a group of 
histidine-rich polypeptides from human parotid saliva by gel filtration 
chromatography on Sephadex G-25. This procedure resolved parotid 
secretion proteins into six major fractions {A-F), and analysis of proteins in 
each fraction by the cationic PAGE system identified these proteins 
primarily in fraction C, although small quantities were also found in 
fraction D, E, and F. 
The amino acid compositions of HRPs described by Baum et al. 
[ 1977 a] were very similar to those of the Pb proteins of Peters and Azen 
[1977]. In addition, the amino acid compositions of both the HRPs and Pb 
proteins were veiy similar to that of Component II isolated by Hay [1975]. 
The isolation and purification of a neutral HRP from human parotid 
secretion by Oppenheim et al. [ 1986] established the relationship between 
Component II [Hay, 1975] and HRP 1 [Baum et al., 1976] and Pbb [Peters 
and Azen, 1977]. The neutral HRP was the first histidine-rich protein for 
which the primary structure was determined. Oppenheim et al. [ 1986] used 
two different isolation procedures to separate these proteins from other 
proteins in human parotid secretion. The first method included anion 
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exchange chromatography on DEAE Sephadex A-25, cation exchange 
chromatography on CM Bio-Gel A, and final purification by gel filtration 
chromatography on Bio-Gel P-6. The second method included 
chromatography on Trisac:ryl M DEAE and gel filtration chromatography on 
a Bio-Gel P-6. The amino acid sequence of the neutral HRP was determined 
by automated Edman degradation of the intact protein, t:ryptic and 
Staphylococcus aureus VB protease peptides, and digestion with 
carboxypeptidase A. The neutral HRP contained 38 amino acid residues, 
had a molecular weight of 4929, contained 7 histidine, 4 arginine, 3 aspartic 
acid, 3 glutamic acid residues, and one phosphoserine at position 2. 
However, this protein lacked threonine, alanine, valine, cysteine, and 
isoleucine. Carbohydrate analysis revealed absence of sugar moities. 
Analysis of hydropathicity [Kyte and Doolittle, 1982] suggested that the 
peptide was entirely hydrophilic. Seconda:ry structure analysis [Chou and 
Fasman, 1979] predicted short alpha helixes from residues 2-7 and 12-19, 
three beta-turns involving residues 8-11, 20-23, and 31-34, and a beta-
pleated sheet from residues 26-29 and 35-38 in the carboxyl-terminal 
region of the molecule. Assuming minimal charge contributions from 
histidine and one negative charge from phosphoserine at pH 7 .0, the net 
charge on this molecule is zero, balanced by an equal contribution of basic 
and acidic residues. From a comparison of electrophoretic properties, amino 
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acid composition and partial functional characterization, it can be 
concluded that the neutral HRP, Component II, HRP 1 and Pbb are the 
same protein. 
This neutral HRP is an active inhibitor of hydroxyapatite crystal 
growth in solutions supersaturated with respect to calcium phosphate salts 
and is likely to play a crucial role in the stabilization of mineral-solute 
interactions in oral fluid [Oppenheim et al., 1986]. It had already been 
shown that the neutral HRP may be an important molecule due to its 
affinity for hydroxyapatite surfaces implying that it may be a precursor of 
the acquired enamel pellicle [Hay, 1975]. In addition, the neutral HRP was 
shown to be a potent inhibitor of C. albicans germination and therefore may 
be a significant component of the antimicrobial host defense system in the 
oral cavity. 
Oppenheim et al. [1988] introduced a new nomenclature for the HRPs 
and named these proteins "histatins." Histatin 1, 3, and 5 were isolated 
from human parotid secretions and the complete amino acid sequences 
revealed that these consisted of 38, 32, and 24 amino acids, having 
molecular weights of 4929, 4063, and 3037, respectively. All proteins 
contained seven histidine residues that comprised 18-29% of the total 
amino acids. The complete amino acid sequences were determined by 
au to mated Edman degradation of the proteins and tryptic and S. aureus V8 
22 
protease peptides. These studies revealed that the first 24 amino acid 
residues of all three histatins are identical with the exception of the 
substitution of Glu at residue 4 and Arg at residue 11 in histatin 1 for Ala 
and Lys in histatin 3 and 5. The sequence, -Glu-Phe-Pro-Phe-Tyr-Gly-Asp-
Tyr-Gly- (residues 23-31), in histatin 1 is absent in histatin 3, and the 
sequence, -Gly-Tyr-Arg- (residues 23-25), in histatin 3 is absent in histatin 
1. Histatin 1 contains a phosphorylated serine at residue 2 whereas 
histatins 3 and 5 lack inorganic phosphate. The complete sequence of 
histatin 5 is contained within the amino terminal 24 residues of histatin 3. 
Structural data suggested that histatin 1 and histatin 3 derive from different 
genes, and that histatin 5 is a degradation product of histatin 3. Histatin 1, 
3, and 5 were named major histatins because they represent 70-80% of 
total histatins and occur in a proportion of 3: 1:3, respectively. Whereas 
histatin 1 is neutral with a net charge of zero, histatin 3 and 5 are basic 
proteins with a net charge of +5. 
The single step procedure using gel filtration on Bio-Gel P-2 proved to 
be a valuable tool in the isolation of histatins. The elution profile of one gram 
of human parotid saliva protein shows a large void volume peak containing 
the bulk of the proteins, a salt peak, and finally a late peak which eluted 
after 2 column volumes. The proteins retained on Bio-Gel P-2 which eluted 
in several broad peaks, were shown to be histatins. When these proteins 
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were subjected to RP-HPLC on a C1s column using a linear acetonitrile 
gradient, histatin 1-7 were almost completely resolved into distinct peaks 
[Oppenheim et al., 1988]. 
Troxler et al. [ 1990] elucidated the complete structural relationship 
between all members of the family of human salivary histatins (Table 4). 
Electrophoretic analysis of human parotid secretion in a cationic PAGE 
system showed that the bottom half of the electrophoretogram contained 
three pairs of bands which represented the three major histatins 1, 3, and 5 
and minor histatins 2, 4, and 6. The same pattern of bands was present 
when human submandibular/sublingual secretion was examined showing 
for the first time that histatins are products of both pairs of major salivary 
glands. 
In this study the minor histatins 2, 4, 6, and the more cathodically 
migrating histatins 7 -12, were also sequenced and all displayed a high 
degree of homology. With the exception of histatin 2, which is a proteolytic 
fragment of histatin 1, all other minor histatins were derived from histatin 3 
by tiyptic-like (proteolytic cleavage at lysine and arginine residues) or 
chymotiyptic-like (proteolytic cleavage at phenylalanine) cleavages. The 
proteolytic cleavage appeared to be specific and could have occurred 
intracellularly, during exocytosis or after secretion in the acinar lumen or in 
Stenson's duct prior to release into the oral environment. Importantly, it was 
shown that minor histatins were not generated during the isolation 
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Table 4: Complete amino acid sequences of all members of the family of human 
salivary histatins. 
Protein Sequences 
1 10 20 30 38 
Histatin 1: o s H E K R H H G Y R R K F H E K H H s H R E F P FY G o Y G s N Y L Y o N 
Histatin 2: RKFHEKHHSHREFPFYGDYGSNYLYDN 
Histatin 3: o s H A K R H H G Y K R K F H E K H H s H R G y R - - - - - - s N y L y o N 
Histatin 4: RKFHEKHHSHRGYR--- - - -SNYLYDN 
Histatin 5: o s H A K R H H G Y K R K F H E K H H s H R G Y 
Histatin 6: o s H A K R H H G Y K R K F H E K H H s H R G y R 
Histatin 7: RKFHEKHHSHRGY 
Histatin 8: KFHEKHHSHRGY 
Histatin 9: RKFHEKHHSHRGYR 
Histatin 10: KFHEKHHSHRGYR 
Histatin 11: KRHHGYKR 
Histatin 12: KRHHGYK 
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procedure because the electrophoretic pattern of histatins in the cationic 
PAGE system was the same before and after chromatography on Bio-Gel P-2 
[Troxler et al., 1990]. 
Sugiyama et al. [1990] described a new method for isolation of 
histidine-rich polypeptides from human whole saliva by a single step affinity 
chromatography procedure using heparin-Ultrogel. Three histidine-rich 
polypeptides, referred to as B-1, C-1, and D-2, were differentially eluted 
from the heparin-Ultrogel matrix and automated Edman degradation of 
these revealed that B-1 was histatin 1, C-1 was histatin 3 and D-2 was 
histatin 5. 
BIOLOGICAL POTENTIAL OF HISTATINS 
The potential biological activities of histatins are of great interest and 
have been widely investigated. Holbrook and Molan [ 1975] showed that a 
mixture of partially purified histatins were active in enhancing the glycolytic 
activity of certain oral bacteria. Component II described by Hay [ 1975], now 
known as histatin 1, exhibited a high affinity for hydroxyapatite and dental 
enamel surfaces, suggesting that it may be involved in the early formation of 
the acquired enamel pellicle. Preparations enriched in histatins induced 
changes in membrane permeability and appear to have anti-bacterial 
properties against Streptococcus mutans [McKay et al., 1979 and 1984]. 
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Histatin 1, 3, and 5 are bactericidal against members of the mutans group 
of Streptococci, with histatin 5 being the most potent, exhibiting complete 
killing at 50-100 µM [Xu and Oppenheim, 1990). Furthermore, Pollock et al. 
[1984) found that histatins inhibited growth and could kill C. albicans. 
These antimicrobial and antifungal properties of histatins suggested that 
they may play an important role in the host non-immune defense system in 
the oral cavity. 
Enhancement of glycolysis 
The enhancement of the glycolysis of the salivary microflora by 
salivary components has been investigated by many researchers with the 
goal of identifying the factors responsible. This concept is of great 
importance in dental health because of the importance of acid production as 
a by-product of microbial glycolysis in the initiation and progression of 
caries. Many approaches were used to attempt to identify the glycolysis-
enhancing factor in glandular secretions and whole saliva, and these studies 
yielded different and sometimes conflicting results. Hartles et al. [ 1955) were 
the first to observe the glycolysis-enhancing activity of substances known to 
occur in whole saliva. Later, Kawasaki et al. [ 1964) isolated a "derived 
protein" of molecular weight 7 ,000-11,000 that stimulated glycolysis. 
Ishihara [ 1967] found peptides of relatively low molecular weight to be 
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responsible in the enhancement of the glycolysis. Molan and Hartles [ 1969] 
chromatographed parotid secretion on Sephadex G-25 and tested the ability 
of various fractions to stimulate glycolysis in oral bacteria. A fraction 
containing low molecular components stimulated glycolysis, and infrared 
absorption spectroscopy identified one of the components in the active 
fraction as urea. 
Holbrook and Molan [ 1975] reported that a small basic peptide was 
present in human parotid secretion that markedly activated glycolysis of 
oral microorganisms. This peptide was shown to have a low molecular 
weight since it was eluted from Sephadex G-25 just before urea. Amino acid 
analysis indicated the minimum molecular weight of this small basic 
peptide was between 2,500 and 3,000. Further analyses showed that the 
peptide exhibited an unusually high affinity for Bio-Gel P-2 and could be 
eluted from the resin by 1.0 M NaCl. Amino acid analysis revealed a high 
proportion of histidine (26 mol%), lysine (17 mo!%), and arginine (13 mo!%). 
Cationic polyacrylamide disc gel electrophoresis of the histidine-rich protein 
retained on Bio-Gel P-2 revealed a single band that was the most rapidly 
migrating component in parotid secretion. 
Bonilla (1969] had previously shown that a low molecular weight 
protein in parotid secretion absorbed to Bio-Gel P-2 (a cross-linked 
polyacrylamide gel), and that this protein behaved as a basic protein in a 
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cationic PAGE system. This led Holbrook and Molan [ 1975] to the 
conclusion that the low molecular weight peptide that enhanced glycolytic 
activity in their studies may be the same as the strongly cationic peptide 
described by Bonilla [ 1969). 
More recently, Xu et al. [ 1995) determined the effects of human 
salivary histatins and histatin fragments on the inhibition of glycolysis in S. 
rattus, strain BHT, a well-known cariogenic microorganism. Glycolysis was 
measured as acid production from bacterial glucose catabolism. Bacteria 
were incubated at 37°C for 0-60 min in PBS, pH 7.4, with 50 mM glucose in 
the presence or absence of histatin 3 or histatin peptides corresponding to 
the N-terminal (residue 1-11), middle (residue 12-24), and C-terminal 
(residue 25-32) regions of histatin 3. They observed that histatin 3 and the 
middle region peptide are effective inhibitors of glycolysis in S. rattus and 
concluded that the middle portion of histatin 3 (residues 12-24) represented 
the functional domain for the inhibition of glycolysis. These studies 
confirmed and extended earlier work with impure histatin preparations, 
suggesting that salivary histatins do indeed play an important role in the 
prevention of caries development. 
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Formation of the acquired enamel pellicle 
The acquired enamel pellicle is a proteinaceous film on tooth surfaces 
separating the outermost portion of the enamel surface from the innermost 
microbial layer. It has been implicated in controlling the mineral solution 
dynamics of enamel and in exerting selectivity on bacterial colonization. 
Hay et al. [ 1975] described for the first time the isolation and partial 
characterization of a histidine-rich peptide (e.g., Component II = histatin 1) 
which shows high affinity for hydroxyapatite surfaces and dental enamel 
surfaces, suggesting a possible role for this peptide in the early stages of the 
formation of the acquired enamel pellicle. Oppenheim et al. [ 1986] reported 
the isolation of a neutral histidine-rich polypeptide (histatin 1), which 
exhibited high affinity for hydroxyapatite surfaces and inhibited crystal 
growth from solutions supersaturated with respect to calcium phosphate 
salts. Histatin 1 is similar to the PRPs and statherin by virtue of its high 
affinity for hydroxyapatite, but differs markedly in amino acid composition 
in that it is the only known inhibitor of crystal growth which contains just 
one phosphoserine residue. PRPs have two phosphoserines located at 
residue 8 and 22, whereas statherin has two vicinal phosphoserines located 
at residue 2 and 3 [Schlesinger and Hay, 1977; Hay et al., 1988]. 
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Antibacterial activity 
The discovery and isolation of these basic small salivary proteins (i.e., 
histatins), encouraged many investigators to study the structure-function 
relationships of these proteins. Antibacterial properties of histatins were 
suspected because strongly cationic agents from several sources were 
known to exhibit this biological activity. For example, lysozyme [Pollack et 
al., 1983] and cationic proteins from polymorphonuclear leukocytes [Lehrer 
et al., 1975] and macrophages [Patterson-Delafield et al., 1980] display 
microbicidal and membrane permeability effects against both gram-positive 
and gram-negative bacteria. MacKay et al. [ 1979] described for the first time 
the effects of salivary polypeptides on permeability of bacterial membranes. 
These investigators reported that histidine-rich polypeptides (i.e., histatins) 
in salivary secretions increased membrane permeability of S. mutans BHT 
cells. S. mutans BHT cells were radiolabeled with {14C)-labeled nicotinamide 
and incubated with histatins at a concentration of 25 µg/ml. This resulted 
in a 32%, 43%, and 43% release of [14C]-label after 8, 60, and 180 min, 
respectively. In the control experiment with hen's egg lysozyme (a protein 
known to interact with bacterial membranes), release of radioactivity after 
incubation for 8, 60, and 180 min was 78%, 101 %, and 100%. In addition, 
a 44% reduction in colony forming units was also obseived after incubation 
of oral bacteria with a mixture of partially purified histatins for one hour. 
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Iacona et al. [1983] analyzed histatin concentrations in parotid and 
submandibular secretion from caries-resistant and caries-susceptible 
adults. Densitometric analysis of cationic PAGE gels revealed that parotid 
and su bmandibular secretions from caries-resistant individuals contained 
more histatins than did these secretions from caries-susceptible adults. This 
suggested a positive relationship between the level of histatins in salivary 
secretions and caries resistance. 
McKay et al. [ 1984] tested, for the first time, the effects of salivary 
histatins on S. mutans BHT (serotype b), S. mutans GS5 (serotype c), and S. 
mutans SB (serotype c). Both inhibition of growth and cell division were 
enhanced by preincubation of bacteria with histatins in low-ionic-strength 
buffers at acidic or neutral pH before dilution into an enriched growth 
media. Bacteria preincu bated with histatins ( 100-500 µg/ ml) showed 
delayed growth when placed in an enriched growth media containing 2-10 
µg/ml of histatins. The growth of S. mutans BHT was inhibited at 2 ~tg/ml of 
histatins whereas S. mutans GS5 required 10 ~tg/ ml of histatins for growth 
inhibition. Preincubation at pH 6.8 reduced the effectiveness of histatins to 
inhibit growth. However, preincubation at pH 5.2 led to an increase in the 
ability of histatins to inhibit both growth and cell viability. When bacterial 
cells were incubated with histatins at 250 ~tg/ ml, no growth was observed 
for a period of 48 hours. This effect was even greater when cells were 
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exposed to histatins under non-growing conditions in phosphate buffer at 
neutral pH than in rich medium under growing conditions. The latter result 
could be interpreted to mean that histatins became bound to various 
components in the rich growth medium and therefore were unavailable to 
.exert their "cidal" effects on the bacteria. 
Xu and Oppenheim [ 1990] investigated the effects of histatin 1, 3, and 
5 on bacterial viability and growth inhibition of the mutans Streptococci 
serotypes a, b, c, d, e, f, and g. Spectrophotometric measurements and disc 
agar diffusion techniques were utilized to determine the growth inhibition of 
bacteria. The bacteriocidal effect was enhanced at an acidic pH between 4.0 
and 5.0. Histatin 1 and 5 are inhibitory for all serotypes and histatin 3 for 
serotypes a, b, c, d, f, and g, with histatin 5 being the most potent. At pH 
6.0,-8.0, complete inhibition was observed for all serotypes tested at 
concentrations 100-200 µM for histatin 1, 50-200 µM for histatin 3, and 50-
100 µM for histatin 5. More recently, the effect of his ta tin 5 on several 
strains of Actinomyces was investigated [Kalpidis et al., 1992]. First, it was 
shown that histatin 5 exhibited bactericidal activity against A viscosus, A. 
naeslundii, and A. odontolyticus, and that complete loss of viability was 
observed at concentrations higher than 40 ~tg/ml. Second, histatin 5 bound 
did not promote attachment of Actinomyces strains. Third, histatin 5 does 
not appear to promote adherence of A viscosus to the tooth surface. This 
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was based on the observation that when an artificial pellicle consisting of 
histatin 5 bound to hydroxyapatite beads was incubated with A viscosus, 
no adherence was observed. However, in the control where PRPs were 
attached to hydroxyapatite beads, substantial binding of A. viscocus was 
observed. 
Finally, histatin 5 was shown to inhibit A actinomycetemcomitans 
leukotoxin by preventing it from binding to human PMNs [Murakami et al., 
1995]. A 50% inhibition of leukotoxin-mediated LDH released from PMNs 
was achieved with 150 µM of histatin 5. 
Antifungal activity 
Pollack et al. [ 1984] reported the an tif ungal effect of histatins on the 
pathogenic yeast, C. albicans. C. albicans strains were preincubated with 
histatins (250 µg/ml) or lysozyme (250 µg/ml) for two hours. 100 µl aliquots 
were transferred to yeast synthetic growth medium, with or without 
histatins or lysozyme, and cell growth was monitored spectrophotometrically 
at 600 nm as a function of time. Preincubation with histatins inhibited 
growth of C. albicans moreso than preincubation with lysozyme. Addition of 
histatins to the growth medium caused an even greater inhibitory effect. 
Complete inhibition of growth was detected at 250 µg/ ml of histatins with or 
without preincubation. In another experiment, C. albicans were directly 
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inoculated into the medium with various histatin concentrations ranging 
from 0.005 to 0.25 µM. Complete growth inhibition and complete loss of 
viability was observed at a histatin concentration of 25 µg/ml. It was shown 
that at higher cell densities a greater concentration of histatins was required 
to inhibit growth. Under non-growing conditions, a 90% bactericidal effect 
was observed with 100 µg/ml of histatins after 30 minutes of incubation. 
Also, loss of cell viability was correlated with release of potassium ions from 
C. albicans. At 50 or 100 µg/ ml of histatins, greater than 90% of potassium 
was released after incubation for 30 minutes, and at 250 µg/ml, 100% of 
potassium was released. 
Oppenheim et al. [ 1986] examined the effects of histatin 1, 3, and 5 
on the inhibition of blastospore germination and viability of C. albicans. 
They reported that 50% to 80% inhibition of germination occurred at 
histatin 1 concentrations of 0.4 µM and 1.6 µM, whereas only 20% 
inhibition was observed with lysozyme (the standard test protein) at a 
concentration of 83 µM. This striking result showed that histatin 1 is 50 to 
200 times more active than lysozyme in inhibition of C. albicans blastospore 
germination. In addition, Oppenheim et al. [ 1988] reported that histatin 1, 
3, and 5 are all active agents in the killing . of C. albicans in a dose-
dependent manner. The candidacidal potential was shown to be inversely 
correlated with molecular weight such that the killing potential was: histatin 
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5 > histatin 3 > histatin 1. For all three histatins, 100% killing was observed 
at a concentration of 27 µM. The end point at which killing activity could be 
obseived was 1.69 µM for histatin 1, 0.84 µM for histatin 3, and 0.21 µM for 
histatin 5. 
Xu et al. (1990] described the isolation and anticandidal properties of 
the major macaque histatin (M-histatin 1) from the parotid secretion of the 
subhuman primate, Macaca fascicularis. Three different assays were 
performed to compare the antimicrobial activities of M-histatin 1 and 
human histatin 1, 3, and 5. The three assays, which measured blastospore 
killing, the killing of germinated cells, and the inhibition of germination, all 
showed that M-histatin 1 displays an equivalent or even greater biological 
activity than do human histatins 1, 3, and 5. 
Raj et al. [ 1990] studied the dependence of sequence, chain length, 
and helical conformation of histatin 5, in relation to its candidacidal activity. 
Histatin 5 and several smaller histatin peptides were synthesized by solid-
phase procedures. Native histatin 5, isolated from parotid saliva, and 
synthetic histatin 5 were similar in their candidacidal activity. The Cl6 
fragment (residue 9-24) showed similar activity to histatin 5. The N 16 
fragment (residue 1-16) was far less active than the C 14 fragment (residue 
11-24). These investigators concluded that a sequence in the C-terminal 
region of histatin 5, with a minimum chain length of 14 residues and the 
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potential to form a-helices, are important structural requirements for 
candidacidal activity. Histatins which can form a-helical conformations in 
non-aqueous hydrophobic environments may interact with C. albicans and 
alter membrane permeability resulting in cell death. 
Xu et al. [ 1991] described the functional characterization of histatins 
1, 3, and 5 in relation to their anticandidal activity. Assays evaluating the 
killing of blastoconidia, the killing of germinated cells, and the inhibition of 
germination were developed to evaluate their candidacidal activity. All three 
histatins demonstrated anticandidal activity. In killing of blastoconidia and 
killing of germinated cells, histatin 5 was the most potent, followed by 
histatin 3 and then histatin 1. However, in inhibition of germination, 
histatin 3 exhibited more activity than either histatin 1 or histatin 5. 
Candidacidal activity of histatin was shown to be inversely proportional to 
both the ionic strength and the divalent cation concentration in the 
medium. Reduction of pH enhanced the candidacidal activity of histatin 1 
and 3, while the activity of histatin 5 was pH-independent between pH 4.0 
and 8.0. Log phase C. albicans cells were more susceptible to histatin 1 and 
3 (where the LD50 values were 4.0 µM and 2.8 µM, respectively) than cells in 
stationary phase (where the LD50 values were 5.8 µM and 4.6 µM). In either 
growth phase, C. albicans was more vulnerable to histatin 5 than to histatin 
1 and 3. 
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Xu et al. [ 1992] determined the importance of histidine residues in 
the anticandidal activity of histatin 5. Modification of 1 or 2 histidine 
residues (out of a total of seven) with the reagent, diethylpyrocarbonate, 
slightly reduced anticandidal activity. Covalent modification of 3 to 5 
histidine residues decreased the anticandidal activity even more 
dramatically. No anticandidal activity was observed after covalent 
modification of all seven histidine residues. These studies clearly 
demonstrate the importance of histidine residues in the multiple biological 
activities of histatins. 
Histamine release 
Sugiyama et al. [ 1990] presented a new method of purifying and 
characterizing histatins from human whole saliva. Isolation of histatins was 
performed by a two step procedure using a heparin-Ultrogel column 
followed by reversed-phase HPLC. Earlier, Sugiyama et al. [ 1985a] isolated a 
histatin which they called "F-A" from human parotid secretion. According 
to the nomenclature of Oppenheim [ 1988], this peptide, histatin 5, was 
shown to release histamine from isolated rat mast cells [Sugiyama et al., 
1985b]. Mast cells were incubated with histatin 5 in PBS (pH 7 .2) for 10 min 
at 37°C, and histamine release was determined fluorometrically. Incubation 
with histatin 3 and 5 induced 60% release at a concentration of 40 ~tM. 
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Histatin 1 displayed a very weak activity, requiring a concentration of 130 
µM to achieve the same degree of histamine release. Positively charged 
amino acids and the secondary structure of histatin 5 were considered to 
play an important role in the release of histamine. It was proposed that 
histatins might be involved in the acute inflammatory reaction by 
stimulating histamine release from the mast cells. 
Antiproteolytic activity 
Another important property of histatins was elucidated by Nishikata 
et al. [1991]. They examined the effects of histatin 5 from human parotid 
secretion on various proteases. Histatin 5 was found to be a strong inhibitor 
of a protease from Bacteroides gi.ngivalis, exhibiting complete inhibition at 
10 µM and inhibition even at concentrations as low as 1 µM. Inhibition of 
clostripain was also observed, but to a lesser extent. Collagenase was 
moderately inhibited. Trypsin, thrombin, papain, chymotrypsin, and 
elastase were almost unaffected. The inhibition of B. gi.ngivalis protease and 
clostripain by histatin 5 appears to be specific since both enzymes share 
similar enzymatic properties. They are sulfhydryl-dependent and have a 
cleavage specificity similar to that of trypsin. They also show a marked 
preference for arginine over lysine. It has been proposed that histatin 5 
inhibited B. gi.ngivalis protease and clostripain by binding to the protease-
39 
active site forming a non-covalent complex thereby inactivating the protease. 
Since B. gi,ngivalis has been strongly implicated in tissue destruction in 
periodontal disease, histatins may play an important role as a host-derived 
defense against periodontal disease. 
Inhibition of coaggregation 
Inhibition of coaggregation by human salivary histatins has been 
investigated with great interest since Slots and Gibbons [ 1978) reported that 
adherence of P. gi,ngi,valis to hydroxyapatatite surfaces and buccal epithelial 
cells is inhibited by human whole saliva. Murakami et al. [ 1991] determined 
the effects of histatins on coaggregation of P. gi,ngivalis 381 and Steptococcus 
mitis ATCC 9811. The inhibition of coaggregation was determined by using a 
turbidimetric assay. The coaggregation activity was significantly inhibited by 
synthetic histatin 5 and 8. Histatin 5 was more potent than histatin 8, 
reaching 50% inhibition at 14 µM and 62 µM, respectively. Lysozyme was 
the most potent in inhibiting bacterial coaggregation, requiring only 1.3 µM 
for the same inhibitory effect. Basic peptides and proteins containing 
histidine, arginine, and lysine residues function by binding to P. gi,ngivalis 
cell surfaces. They proposed that lysozyme, histatin 5, and to a lesser 
extent, histatin 8, may modulate the attachment of P. gi,ngi,valis to gram-
positive bacteria in the mouth. 
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Inhibition of hemagglutination 
It has been shown that the hemagglutinating activity of Bacteroides 
gi.ngivalis is inhibited by human whole saliva, especially by high molecular 
weight components [Slots and Gibbons, 1978]. However, little attention has 
been paid to the inhibitoiy properties of low molecular-weight proteins on 
hemagglutinating activity. Murakami et al. [ 1990] described the inhibitoiy 
effects of a synthetic histatin 5 and two shorter synthetic peptides contained 
within histatin 5. Peptide I was the shortest and consisted of residue 17-24 
of histatin 5. Peptide II was intermediate in length and consisted of residue 
9-24 of histatin 5. Peptide III was the longest, containing 24 residues, and 
was identical in sequence to native histatin 5. Human O-type eiythrocytes 
were used for the hemagglutinating assay. The agglutination mixture was 
incubated for 90 min and evaluated with the naked eye. Hemagglutinating 
activity was also monitored spectrophotometrically by the decrease in 
absorbance at 542 nm, 5 min after start of the reaction. No change of 
absorbance was observed when Peptide III was added to the mixture. The 
hemagglutinating activity was significantly inhibited by synthetic Peptide III, 
moderately by Peptide II, and weakly by Peptide I. Complete inhibition of 
hemagglutination (100%) was achieved with Peptide III at 5 nmole/ml, 
Peptide II at 10 nmole / ml and Peptide I at 100 nmole / ml. They suggested 
that the cationic peptides containing histidine, arginine, and lysine residues 
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may function electrostatically as a binding domain for B. gi,ngivalis and/ or 
erythrocyte surfaces during agglutination. Inhibition of hemagglutination by 
histatin 5 may play an important role in the colonization of B. gi,ngivalis in 
the oral cavity, providing a protective function against development of 
periodontal disease. 
Hemagglutinating activity of B. gi,ngivalis was known to be strongly 
inhibited by histatin 5. However, it was still unclear how binding occurs 
between histatin 5 and P. gi,ngivalis cells. Murakami et al. [ 1991] evaluated 
the histatin-binding capacity of the cells by incubating P. gi,ngivalis 381 with 
1251-histatin 5 in the presence and absence of unlabeled his ta tin 5. The 
binding assay was performed in 1.5 ml polypropylene microcentrifuge tubes 
coated with silicone to reduce the nonspecific binding of histatin. The 
radioactivity associated with pelleted bacteria was quantitated in a gamma 
counter, and binding of histatin 5 was observed within 5 min. The addition 
of unlabeled histatin 5 decreased binding of 1251-histatin 5 to the cells, and 
Scatchard analysis revealed a dissociation constant of 1. 5 x 10-6 M 
indicating binding sites with moderately low affinity. The number of histatin 
5-binding sites per cell was 3600. The binding of histatin 5 to P. gi,ngivalis 
was rapid, reversible, saturable, and specific. They concluded that the 
histatins inhibit the hemagglutinating activity of P. gi,ngi,valis by specific 
binding to a specific component on the bacterial cell. 
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More recently, Murakami et al. [1992] investigated the biological role 
of arginine in the inhibition of hemagglu tination of P. gi.ngivalis by 
examining the effect of histatin 8 (residue 13-24 of histatin 5) and six 
smaller peptides contained within histatin 8 on this process (Table 5). 
Peptide I and Peptide II showed almost 100% inhibition of hemagglu tination 
at 20 µM, and Peptide III and IV showed 100% inhibition of 
hemagglutination at 100 µM. Peptide VI, in which an arginine residue is not 
present, was far less active than Peptide IV which contained an arginine 
residue at the carboxyl terminus. These results provide strong evidence for 
the role of arginine in the inhibition of hemagglutination. 
QUANTIFICATION OF SALIVARY HISTATINS 
It is now well established that salivary histatins are important 
components in the non-immune oral defense system. Several groups of 
investigators have conducted studies to determine histatin 
concentrations in HIV-positive patients to relate levels of these proteins 
to the presence of oral candidiasis, herpetic infection, hairy leukoplakia, 
and aphthous stomatitis. However, due to the different methods utilized 
for saliva collection, handling of saliva samples, and quantitation 
techniques, these studies have yielded different and often contradictory 
results. 
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Table 5: Amino acid sequence of histatins 5 and 8 (HIS) and the synthetic peptides 
(PEP) . 
HIS 5 D S H A K R H A G Y K R L F H E K H H S H R G Y 
* HIS 8 K F H E K H H S H R G Y 
PEP I K F H E K H H S H R G Y 
PEP II K F H E K H H S H R 
PEP III K H H S H R G y 
PEP IV K H H S H R 
PEP V K F H EK 
PEP VI K H H S H 
*The sequence of histatin 8 as defined by Troxler et al. [1990]. 
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Atkinson et al. [ 1990] determined levels of four salivary anti-
microbial proteins (lactoferrin, lysozyme, secretory IgA, and histatins) in 
parotid and submandibular secretion under stimulated and 
unstimulated conditions using a competitive ELISA. The results indicated 
an overall increase in the concentration of anti-microbial proteins in the 
saliva of HIV-infected patients. Stimulated submandibular/sublingual 
secretion revealed the highest increase in the level of the antimicrobial 
proteins with a decrease in the fluid output, suggesting that the 
submandibular/sublingual secretion may be altered after HIV infection. 
In parotid secretion from control subjects, the mean histatin 
concentrations were 0.35 mg% and 0.98 mg% under stimulated and 
unstimulated conditions, respectively. In submandibular / sublingual 
secretion from control subjects, the mean histatin concentrations were 
0.36 mg% and 1.16 mg% under stimulated and unstimulated conditions, 
respectively. 
Mandel et al. [ 1992] compared the composition of stimulated 
parotid secretion in AIDS patients on a longitudinal basis at four-month 
intervals over a one-year period, using immunochemical techniques 
(rocket electrophoresis) to quantitate total histatins. The results indicated 
that HIV-positive patients maintained normal flow rates and secreted 
normal or elevated levels of protective proteins. However, a subgroup of 
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HIV-positive patients displayed a decrease in flow rate over time and a 
diminution in output of histatins. Lactoferrin, secretory IgA, and 
histatins had comparable levels in the HIV-positive and HIV-negative 
groups. The results indicated that histatin concentrations in healthy 
patients ranged between 1.1 mg% and 1.5 mg%. These studies suggested 
that the protective capacity of salivary glands was not impaired in HIV-
positive patients. 
More recently, Lal et al. [ 1992b] used capillary electrophoresis to 
compare the concentration of histatins 1-6 and lysozyme in parotid 
secretion from twelve healthy adult controls and twelve adult AIDS 
patients. Contrary to the results reported by Atkinson et al. [ 1990], 
histatin concentrations in AIDS patients showed statistically significant 
decreases when compared to healthy adult controls. For parotid 
secretion of AIDS patients, the range of histatins was 0.0-18.5 mg% 
(mean= 4.9 mg%) compared with parotid secretion from healthy subjects 
where the range was 5.5-42.5 mg% (mean = 16.9 mg%). For 
submandibular/sublingual secretion in AIDS patients, the range was 
0.0-16.1 mg% (mean= 5.6 mg%) compared with 5.5-34.7 mg% (mean= 
16.7 mg%) in healthy subjects. These results which show lower histatin 
concentrations in AIDS patients are the opposite of those of Atkinson et 
46 
al. [ 1990] who reported higher histatin concentrations in patients 
infected with HIV. 
Jen sen et al. [ 1994] were the first to investigate physiological 
regulation of secretion of histatins and statherins in human parotid 
secretion under various physiological stimuli (chewing short or long 
tubing, 0.5%, 1.5%, and 5% citric acid). Using a sandwich ELISA, the 
secretory rate of both histatins and statherins was shown to increase 
together with an increase in flow rate. The relative flow rates achieved 
under the various stimuli were: 5% citric acid > 1.5% citric acid > 0.5% 
citric acid > chewing long tubing > chewing short tubing > resting state. 
Interestingly, the relative histatin concentrations at these flow rates were: 
5% citric acid > chewing long tubing = 1.5% citric acid = 0.5% citric acid 
= chewing short tu bing > resting state. It is noteworthy that the histatin 
concentrations obtained during stimulation with 0.5% citric acid were 
very similar to those reported by Lal et al. [ 1992b] and ranged from 2.5 
mg¾-30.4 mg% (mean = 3.8 mg%). In addition, Jensen et al. [1994] 
found that histatin concentrations were reduced 58%-72% by the r3i-
adrenolytic antagonist, metoprolol, but not the a 1-adrenolytic antagonist, 
prazosin. They concluded that P1-adrenolytic receptors are important in 
the stimulus-secretion coupling of these proteins, and the reduction in 
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flow rate during treatment with p1-adrenolytic agents may diminish the 
protective function of histatins and statherin. 
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MATERIALS AND METHODS 
Donor selection 
Saliva was collected from 19 healthy adult donors (ten males and nine 
females) ranging in age from 25 to 38 years old. The subjects were 
instructed not to drink, eat, or smoke at least one hour prior to collections. 
Each subject signed an informed consent form approved by the Institutional 
Review Board for Human Research at Boston University Medical Center. 
Sample collection and preparation 
Collections were performed between 9:00 a.m. and 11:30 a.m., in 
order to minimize the effect of a possible circadian variation in salivary 
composition [Dawes, 1974]. For these experiments, 10 ml of parotid saliva 
were collected from both glands in polyethylene graduated cylinders chilled 
on ice using a pair of Carlson-Crittenden devices [Carlson & Crittenden, 
1910], located at the emergence of Stenson's duct by negative pressure as 
previously described by Curby [ 1953). Unstimulated secretion and secretion 
stimulated with sour lemon candies (Regal Crown, Trebor Sharps Ltd., 
London, England) were collected. The flow rate for each donor was 
monitored and flow rates were expressed as ml/min/2 glands. For each 10 
ml sample, 8 ml was dialyzed (Spectra/PorR membrane; molecular weight 
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cut-off of 1,000 daltons) against 6 X 10 liters of deionized water over a 
period of 12 hours, and the samples were frozen and lyophilized. After 
lyophilization, the samples were disolved in 2 ml of deionized water resulting 
in a four-fold concentration. The remaining 2 ml of each sample was stored 
at -20°C without dialysis for immunological analysis. 
A similar procedure was followed for the collection of 
submandibular/sublingual secretion. Collections (approximately 25 ml) 
were made with the aid of a customized device applied to the 
su bmandibular / su blingual area enabling collection of secretion from the 
paired orifices of Wharton's duct located on the floor of the mouth. For each 
25 ml sample, 20 ml was dialyzed, lyophilized, and dissolved in 2.5 ml of 
deionized water resulting in an eight-fold concentration. The remaining 5 ml 
of each sample was stored at -20°C without dialysis for immunological 
analysis. 
Whole saliva samples (30 ml) were collected by having the subject 
expectorate into a vial while chewing paraffin. The vial was kept on ice and 
contained 20% acetic acid in order to minimize proteolytic activity. Samples 
were centrifuged in an SS34 rotor at 22,000 rpm for 30 min at 4°C and the 
resulting supernatant was used for these studies (whole saliva supernatant 
is subsequently referred to as "whole saliva"). After centrifugation, 24 ml of 
the whole saliva samples were dialyzed against deionized water containing 
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0.5% acetic acid. After samples were lyophilized, they were dissolved in 3 ml 
of deionized water resulting in an eight-fold concentration, and then stored 
at -20°C until used. The remaining 6 ml of each whole saliva sample was 
frozen as described above and used for immunological analyses. 
An initial and final protein assay was performed on each saliva 
sample using a modified Lowiy procedure with bicinchoninic acid (BCA) as 
described [Smith et al., 1985]. Protein concentrations of saliva samples were 
estimated by reference to a standard curve generated with bovine serum 
albumin (Pierce Chemical Company, Rockford, IL). Measurement of total 
protein in samples at the time of collection and after dialysis, lyophilization, 
and reconstitution in distilled water, enabled assessment of protein loss 
during sample preparation. 
Purification of salivary histatins 
Histatins were isolated and purified as previously described by 
Oppenheim et al. [ 1988] and used as standards for both laser densitometer 
analyses of cationic PAGE gels and for immunological measurements. 
Human parotid secretion (100 ml) was collected from a number of donors, 
dialyzed and lyophilized. One gram of protein from human parotid secretion 
was taken up in 50 ml of 0.05M ammonium formate (pH 4) and 
chromatographed on a Bio-Gel P-2 column (Bio-Rad, Richmond, CA). 
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Fractions containing histatins were pooled, lyophilized, dissolved in 2% 
acetic acid and subjected to RP-HPLC on a TSK-ODS C1s column using an 
LKB chromatography system. The column was developed with a complex 
gradient and fractions containing histatins were collected, evaporated to 
dryness in a Speed-vac, dissolved in 2% acetic acid, and rechromatographed 
under isocratic gradient conditions as described [Oppenheim et al., 1988]. 
Purified histatin samples were evaporated to dryness, redissolved in distilled 
water, lyophilized, and stored at -20°C. 
Cationic polyacrylamide gel electrophoresis (PAGE) 
Cationic PAGE gel systems have been widely used for analysis of 
basic proteins in human salivary secretions and whole saliva. Cationic 
PAGE was performed in a pH 2.75 separating gel as described by Baum et 
al. (1977a]. To enhance resolution, the original procedure was modified as 
described by McKay et al. [1982]. Samples were subjected to electrophoresis 
on 15% polyacrylamide slab gels (20 cm x 16 cm; 1.5 mm thick) in a 
Protean II apparatus (Bio-Rad). 
All samples were run in duplicate on separate cationic PAGE gels and 
10 µg of histatin 1, 3, and 5 standard were included on each gel. Samples of 
parotid secretion were loaded at three different concentrations 
corresponding to no dilution, a two-fold concentration, or a four-fold 
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concentration of the original saliva sample. Sample preparation was 
conducted in this manner to insure that the concentration of all major 
histatins would fall within the range of the standard curve. A standard 
curve was generated by subjecting 0.5, 2, 4, 6, 8, and 10 µg of histatin 1, 3, 
and 5 to cationic PAGE followed by densitometric analysis of each histatin 
at each concentration. For saliva samples, only those values that fell within 
the linear portion of the standard curve were used. Samples of 
submandibular/sublingual secretion and whole saliva were treated as 
described above except that each was initially concentrated eight-fold, four-
fold, or two-fold when the lyophilized sample was reconstituted in water. 
The separating gel solution was poured into the apparatus, overlaid 
with 1-butanol to exclude air, and then allowed to polymerize overnight with 
irradiation from a fluorescent light (25 watts) placed 24 inches from the gel 
plates. Sample loading buffer was 40% sucrose and 0.04% methyl green. 
The upper tray buffer was 0.37 M glycine adjusted to pH 4.0 with glacial 
acetic acid and the lower tray buffer was 4% glacial acetic acid (v /v) 
adjusted to pH 4.3 with 45% KOH. After applying samples to wells, 
electrophoresis was carried out at 19 mA until the tracking dye reached the 
top of the separating gel; samples were then electrophoresed at 30 mA until 
the methyl green tracking dye migrated to within 0.5 mm of the bottom of 
the separating gel. The overall running time for this cationic PAGE system in 
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the Protean II apparatus was approximately 12 hours. Gels were fixed in 
20% trichloroacetic acid in water for 30 min, stained for 1 hat 60°C in 7% 
acetic acid, 8% methanol, 0.1 % Coomassie Brilliant Blue R-250, and 85% 
water (v /v). Gels were destained in 10% acetic acid, 10% methanol, and 
80% water (v /v) for 36 to 48 hours at room temperature. 
Densitometric analysis 
Bands of histatin standards and of histatins in saliva samples on 
stained cationic PAGE gels were quantified with a LKB Bromma Ultroscan 
XL Enhanced Laser Densitometer (Pharmacia LKB Biotechnology, Sweden). 
This instrument utilizes a high density laser beam from a helium-neon 
source at 633 nm. Gelscan XL 2.1 software (Pharmacia) with CGI graphic 
software (Graphic Software Systems, Inc. USA.) was used to scan, integrate, 
and determine the quantity of individual histatins. 
Affinity purffication of anti-histatin antibody 
Rabbit anti-histatin peptide antibody (directed against residues 12-24 
of histatin 3) and goat anti-histatin 1 antibody were both affinity purified 
using Pierce's Aminolink™ (Pierce Chemical Co.). 
Affinity chromatography has been used extensively for the purification 
of biological molecules and takes advantage of the binding interactions that 
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occur on the surface of a protein. Specific antigens or antibodies can be 
covalently coupled to an insoluble matrix such as cellulose, agarose, or 
glass beads. These solid phase reagents provide a valuable method for the 
isolation of an antigen (by an immobilized antibody) or antibody (by an 
immobilized antigen). For example, when the gamma globulin fraction of an 
antiserum is passed through a column containing immobilized antigen, IgGs 
specific for the antigen will bind. Other proteins in the antiserum 
preparation (unrelated IgGs and other serum proteins) are washed off, and 
the bound IgGs (directed against immobilized antigen) can be released by 
lowering the pH (e.g., 0.1 M glycine pH 2.8) sufficiently to disrupt the 
antibody-antigen complex. 
AminoLink™ is an agarose matrix activated with aldehydes which 
react with primary amine groups of proteins to form Schiff bases. Reductive 
amination forms a stable covalent linkage with minimal leakage of 
immobilized protein. This reagent was used to prepare a histatin 1 affinity 
column according to the manufacturer's instructions. One ml of rabbit anti-
histatin antiserum or goat an ti-histatin an ti serum was applied to a 10 ml 
histatin affinity column equilibrated with 6 ml PBS (sample buffer). The 
antiserum was allowed to enter the gel and then 0.2 ml of PBS was added 
and the column was incubated at room temperature for one hour. The 
sample was recycled through the column a second time to increase binding 
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of histatin-specific IgGs and followed by washing with 16 ml of PBS. Anti-
histatin IgGs bound to the column were eluted with 10 ml of 0.1 M glycine 
pH 2.8. Fractions (1 ml) were collected and the elution profile of protein from 
the column was monitored by measurement of absorption at 280 nm (A2so). 
Most of the antibody eluted in fractions 2-4, although when larger amounts 
of antiserum were applied to the affinity column, histatin specific IgGs also 
appeared in fractions 5-6. Each 1 ml fraction was neutralized by the 
addition of 50 µ1 of 1 M Tris-HCI, pH 9.5. Fractions containing IgGs were 
pooled, dialyzed against distilled water, and lyophilized. 
Enzyme-linked immunosorbent assay (ELISA) 
A modified double antibody sandwich ELISA was utilized for 
measurement of total histatins in saliva samples. Microtiter plates (96-well; 
Corning Costar, Cambridge, MA) were coated with 100 µ1 of affinity purified 
rabbit anti-histatin IgG (primruy antibody) at 1: 1000 dilution in PBS, pH 7.4 
overnight at 4°C. Wells were washed two times with PBS and then were 
blocked with 300 µl of 2% cold-water fish gelatin (Sigma, St. Louis, MO) in 
PBS for one hour at room temperature. Wells were washed two times with 
PBS containing 0.2% fish gelatin and 0.05% Tween 20 (PBS-Gel-Tween). 
Then, 100 µl of histatin standards and saliva samples were added and 
incubated for one hour at 37°C with gentle shaking, and then wells were 
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washed two times with PBS-Gel-Tween. Goat anti-histatin antibody (100 µl) 
at 1: 1000 dilution in PBS was applied to each well and plates were 
incubated for one hour at 37°C with gentle shaking. After washing as above, 
swan anti-goat antibody ( 100 µl) conjugated with alkaline phosphatase 
(Sigma) at 1:5000 dilution in PBS was applied to each well and plates were 
incubated for one hour at 37°C with gentle shaking and then washed. The 
color reagent was p-nitrophenyl phosphate (1 mg/ml) in 0.1 M Tris-HCl 
containing 2 mM MgC12 , pH 8.8. Application of 100 µl of substrate solution 
to each well was followed by measurement of color development at 405 nm 
in a Dynatech plate reader in the kinetic mode over 15 min. On each plate, 
deionized water (no histatins or saliva) was added to four wells that were 
used as the "BLANK." Reaction rates were used for computation of histatin 
concentrations. 
Protein assay utilizing bicinchoninic acid (BCA) 
Total protein in saliva samples was determined by a modification of 
the Lowry technique utilizing bicinchoninic acid (BCA) as described by 
Smith et al. [1985]. Bovine serum albumin (10 µl of a 2 mg/ml solution) or 
saliva samples ( 10 µl; before and after processing) were added to wells of a 
microtiter plate (Coming Costar). To each well, 200 ~tl of working reagent 
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was added and plates were incubated at 37°C for 30 min. Working reagent 
was prepared by mixing 50 parts of reagent A (sodium carbonate, sodium 
bicarbonate, BCA detection reagent and sodium tartrate in 0.2 N NaOH) 
with 1 part of reagent B (4% copper sulfate solution) immediately prior to 
use. After incubation as above, absorbance at 562 nm was measured in a 
Dynatech plate reader. A standard curve was prepared by plotting 
absorbance at 562 nm versus protein concentration. The protein 
concentration of saliva samples was determined by reference to the 
standard curve. 
Survival of salivary histatin in whole saliva 
Whole saliva (WS) was centrifuged at 15,000 rpm in an 8S34 rotor for 
20 min. The resulting whole saliva supernatant used for these experiments 
is subsequently referred to as "whole saliva." Exogenous histatin 3 (50 µg) 
was added to 200 µl of boiled whole saliva or unboiled whole saliva and the 
mixture were incubated for 0, 1, 5, and 20 min at 37°C. After incubation, 
aliquots of samples were mixed with an equal volume of 0.1 % trifluoroacetic 
acid (TFA) in water, passed through a 10,000 molecular weight cutoff 
membrane, and the filtrate was examined by RP-HPLC on a TSK-ODS C18 
column as described above. Pure histatin 3 (S0~tg) in 400 ~tl of 0.1 % TFA 
was used as a control. 
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Avidity of salivary histatin 
To identify the epitope regions of histatins, peptides were synthesized 
which represented the amino-terminal (SPN; residue 1-11), the middle 
portion (SPM; residue 12-22), and the carboxyl-terminal (SPC; residue 23-
38) of histatin 1. The relative avidity of a goat anti-histatin 1 antibody 
preparation for histatins and histatin peptides was measured in a direct 
ELISA. 
Statistical analysis 
The mean value of histatin 1, 3, and 5 measured densitometrically 
under stimulated conditions was compared with the mean value for each 
individual histatin under unstimulated conditions using the Student's 
paired t test (Gosset, 1908). The comparison between the mean values for 
each individual histatin in parotid secretion versus 
submandibular/sublingual secretion versus whole saliva was made using 
the Student's non-paired t test. The exclusion limit for statistically 
significant differences was set to p < 0. 0 1. 
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RESULTS 
Three major histatins have been found in the secretion of human 
parotid and su bmandibular / su blingual glands and in whole saliva. The 
amino acid sequences of histatin 1, 3, and 5 are presented in Figure lA. 
Comparison of protein profiles of stimulated (S) and unstimulated (US) 
glandular secretion and whole saliva by electrophoresis in a cationic 
PAGE system shows that histatin 1, 3, and 5 appear as three distinct 
bands in the bottom half of the gel (Figure 1 B). These gels are 
representative of the cationic PAGE gels used in the present investigation 
for quantitation of individual histatins by laser densitometry. The 
cationic PAGE system has the advantage of separating histatins from all 
other proteins in glandular secretions and whole saliva in addition to 
providing complete separation of the major histatins from one another. 
Flow rate and total protein concentration in parotid, 
submandibular / sublingual, and whole saliva. 
The mean values for flow rates expressed as volume per pair of 
glands are presented in Table 6. The mean flow rate values for stimulated 
secretion from parotid glands and su bmandibular / su blingual glands were 
almost identical. In contrast, the mean flow rate values for unstimulated 
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A: 
Gene 
HIS 1 
HIS 2 
B: 
Protein Sequences 
1 10 20 30 38 
Histatin 1: D S HE KR H H G Y RR K F HE K H H S H RE F P FY GD Y GS NY LY D N 
Histatin 3: D S H 1A K R H H G Y K R K F H E K H H S H R G Y R - - - - - - S N Y L Y D N 
Histatin 5: D s H A K R H H G Y K R K F H E K H H s H R G Y 
Parotid 
s us 
Submandibular / Sublingual 
s us 
Whole Saliva 
s 
Histatin 1 -+ .. ... .. 
Histatin 3 -+ .. .. ... .. 
Histatin 5 -+ .. ... .. .. 
Figure 1: Major histatins in human salivary glandular secretions and in whole saliva supernatant. 
(A) Amino acid sequences of histatin 1, 3, and 5. Histatin 1 is encoded in the H/S1 
gene, histatin 3 is encoded in the H/S2 gene and histatin 5 is a proteolytic fragment of 
histatin 3. (8) Comparison of protein profiles by cationic PAGE of parotid, 
submandibular/sublingual, and whole saliva supernatant under stimulated (S) and 
unstimulated (US) conditions. Each lane contains the equivalent of 128 µI of the 
original sample. 
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Table 6: Flow rate and total protein concentration in parotid, submandibular/ 
sublingual, and whole saliva . 
Parotid 
SMSL 
Flow rate 
(mVmin/both glands) 
s us 
0.10 ± 0.04 
0.53 ± 0.22 
Whole saliva 
2.56 ± 1.15 
2 .22 ± 0.98 
2.29 ± 1.21 
* 
n 
Data were determined by BCA assay 
19 
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Total protein concentration* 
(mg%) 
s us 
402.3 ± 105.8 
375.9 ± 103.9 
246.4 ± 41.0 
592.5 ± 248.7 
240.3 ± 48.8 
secretion from parotid glands were 5 times lower than those for 
unstimulated secretion from su bmandibular / su blingual glands. In the 
present investigation, the stimulated and unstimulated flow rates of 
su bmandibular / su blingual glands were about 2 times higher than those 
reported by other investigators (see Table 2). The higher values obtained for 
unstimulated flow rates of submandibular/sublingual glands are consistent 
with the "self-stimulatory" effect of the collecting device placed in the 
sublingual space to harvest the secretion. 
Mean flow rates obtained for whole saliva were consistent with 
those reported by others [Crossner, 1984]. It should be noted that there 
was a clear discrepancy between the combined flow rates from both pairs 
of major salivary glands and the flow rate of whole saliva. This is not 
entirely unexpected because stimulated glandular secretions were 
collected under conditions of gustatory stimulation (sour lemon drops), 
whereas whole saliva was collected under conditions of masticatory 
stimulation (chewing paraffin). It is well known from a number of studies 
that higher flow rates are achieved under conditions of gustatory as 
opposed to masticatory stimulation [Watanabe and Dawes, 1988). 
The mean values for total protein concentrations in parotid and 
submandibular/sublingual secretion per pair of glands and in whole saliva 
are given in Table 6. The total protein concentrations in parotid secretion 
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collected under stimulated and unstimulated conditions were 402.3 ± 105.8 
mg°/o and 592.5 ± 248.7 mg°/o, respectively, and the total protein 
concentrations in submandibular/sublingual secretion were 375.9 ± 103.9 
mg°/o and 240.3 ± 48.8 mg°/o, respectively. These values are in general 
agreement with those reported in the literature (see Table 1). However, the 
protein concentration of unstimulated submandibular / sublingual gland 
secretion (i.e., 240.3 mg%) was only 60% as great as that in stimulated 
submandibular/sublingual gland secretion (i.e., 375.9 mg%). This is 
consistent with the well known relationship between flow rate and protein 
concentration in secretions from human salivary glands [Dawes, 1967]. The 
protein concentration in unstimulated secretions is high, and as the flow 
rate increases slightly, the protein concentration declines. However, at 
increasingly faster flow rates the protein concentration rises and can attain 
levels higher than those initially present in unstimulated secretion. 
The mean value and standard deviation of total protein in whole 
saliva were 246.4 ± 41.0 mg% (Table 6). This value is somewhat lower than 
what might be expected based on the protein concentrations of glandular 
secretions which contribute about equally to the volume of whole saliva (see 
Discussion). 
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Measurement of individual histatins by laser densitometry 
The major histatins 1, 3, and 5 constitute 70-80% of total histatins in 
glandular secretions (Oppenheim et al., 1988]. Therefore, measurement of 
each major histatin in a saliva sample can provide a reasonable estimate of 
functionally-active total histatin. Previous studies in this and other 
laboratories have shown that the cationic PAGE system is a reliable and 
reproducible method for separating major histatins from one another and 
from other protein in glandular secretions. In the present investigation, 
individual histatins were measured in parotid secretion, 
submandibular / sublingual secretion, and whole saliva from a cohort of 19 
individuals. Quantitation of histatins was performed by densitometric 
analysis of cationic PAGE gels stained with Coomassie Brilliant Blue R-250. 
Parotid secretion 
Individual and total histatin concentrations in parotid secretion are 
given in Table 7 . For parotid secretions the concentrations ranged from 
1.30-9.49 mg<% for histatin 1, 0.56-12.0 mg% for histatin 3, and 0.87-21.8 
mg<% for histatin 5, respectively. Data obtained by laser densitometric 
analysis of basic gel electrophoretograms showed that histatin 5 displayed a 
higher concentration than both histatin 1 and histatin 3 in both stimulated 
and unstimulated conditions. For stimulated conditions, histatin 1 
concentration ranged from 2.67-7.95 mg% (mean = 4.64 ± 1.85), 1. 10-
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Table 7: Histatin concentrations in parotid secretion. 
* * * Histatin 1 a Histatin 3 b Histatin 5 C Total Histatin 
STIMULATED 
Concentration (mg¾) 
Mean concentration 4.64 ± 1.85 s 5.68 ± 3.32 s 7.32 ± 3.45 s 17.63 ± 8.00 
Range of samples 2.67 - 7.95 1.10-10.0 2.24 - 15.5 6.53 - 30.58 
n 18 18 18 
UNSTIMULATED 
Concentration (mg¾) 
Mean concentration 4.12±2.56 NS 3.91 ± 2.92 s 9.39 ± 5.98 s 17.43±11 .96 
Range of samples 1.30 - 9.49 0.56 - 12.0 0.87 - 21.8 2.72 - 42.46 
n 18 18 18 
d NS s s 
* Data were obtained by laser densitometer analysis of basic gel electrophoretograms. 
a Comparison of histatin 1 and histatin 3 
b Comparison of histatin 3 and histatin 5 
C Comparison of histatin 1 and histatin 5 
d Comparison between stimulated and unstimulated 
s Statistically significant : p < 0.01 
NS Statistically not significant: p > 0.01 
Table 8: Concentrations of histatin in relation to total salivary protein in parotid 
secretion.* 
Total Protein_ 
Samples (mg%) 
Stimulated 402.3 ± 105.8 
Unstimulated 592.5 ± 248. 7 
* 
** 
Mean from 18 donors. 
Determined by BCA assay. 
Histatin 1 
1.15 
0.70 
66 
Histatin 3 
(% of Total Protein) 
1.41 
0.66 
Histatin 5 
1.82 
1.58 
10.0 mg°/o (mean = 5.68 ± 3.32) for histatin 3, and 2.24-15.5 mg°/o (mean = 
7.32 ± 3.45) for histatin 5. For unstimulated conditions, histatin 1 
concentration ranged between 1.30-9.49 mg% (mean = 4.12 ± 2.56), 0.56-
12.0 mg<>/o (mean= 3.91 ± 2.92) for histatin 3, and 0.87-21.8 mg°/o (mean= 
9.39 ± 5.98) for histatin 5. 
Student's paired t test was utilized to compare individual histatin 
concentrations (Table 7) under stimulated and unstimulated conditions. 
Histatin 5 showed a statistically higher concentration in both stimulated 
and unstimulated conditions. Histatin 1 displayed the lowest concentration 
under stimulated conditions whereas histatin 3 displayed the lowest 
concentration under unstimulated conditions. 
The histatin concentration in relation to total salivary protein is given 
in Table 8. Under stimulated conditions histatin 1, 3, and 5 constituted 
1. 15%, 1.41 % and 1.82%, respectively, of the total protein, whereas under 
unstimulated conditions the corresponding values were 0.70%, 0.66%, and 
1.58%, respectively. Thus, the major histatins make up approximately 4% of 
the total protein in stimulated parotid secretion and 3% of the total protein 
in unstimulated parotid secretion. This is significant in view of the histatin 
concentrations required for microbicidal activities (see Discussion). 
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Sub mandibular/ sublingual secretions 
Individual and total histatin concentrations in 
su bmandibular / su blingual secretion are given in Table 9. For 
su bmandibular / su blingual secretions the concentrations ranged from O. 91-
16.1 mg°/o for histatin 1, 0.20-13.88 mg°/o for histatin 3, and 0.31-17.8 mg°/o 
for histatin 5, respectively. Data obtained by laser densitometer analysis of 
basic gel electrophoretograms showed that the concentration of histatin 1, 
histatin 3, and histatin 5 under stimulated conditions was higher than 
under unstimulated conditions. For stimulated conditions, histatin 1 
concentration ranged between 2.03-16.1 mg% (mean = 8.69 ± 3.79), 1.3-
13.88 mg°/o (mean= 6.61 ± 3.51) for histatin 3, and 2.33-17.83 mg% (mean 
= 10.25 ± 4.23) for histatin 5. For unstimulated conditions, histatin 1 
concentrations ranged between 0.91-7.89 mg% (mean= 3.35 ± 1.74), 0.20-
4.04 mg% (mean = 1.26 ± 1.11) for histatin 3, and 0.31-5.84 mg% (mean = 
2.55 ± 1.66) for histatin 5. 
Student's paired t test was utilized to compare individual histatin 
concentrations under stimulated and unstimulated conditions (Table 9). The 
concentration of all three major histatins was higher under stimulated 
conditions compared to unstimulated conditions. Of the three major 
histatins, histatin 5 was the most abundant under stimulated conditions, 
and histatin 1 was the most abundant under unstimulated conditions. 
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Table 9: Histatin concentrations in submandibular/sublingual secretion. 
* Histatin 1 a 
STIMULATED 
Concentration (mg¾) 
Mean concentration 8.69 ± 3.79 s 
Range of samples 2.03 -16.1 
n 19 
UNSTIMULATED 
Concentration (mg¾) 
Mean concentration 3.35 ± 1.74 S 
Range of samples 0.91 - 7.89 
n 19 
d s 
* Histatin 3 
6.61 ± 3.51 
1.33 - 13.88 
19 
1.26 ± 1.11 
0.20 - 4.04 
19 
s 
b 
s 
s 
* Histatin 5 
10.25 ± 4.23 
2.33 - 17.83 
19 
2.55 ± 1.66 
0.31 - 5.84 
19 
s 
C Total Histatin 
s 25.55 ± 10.30 
8.61 - 44.99 
S 7.16±3.99 
1.75-14 .62 
a 
b 
C 
d 
s 
Data were obtained by laser densitometer analysis of basic gel electrophoretograms. 
Comparison of histatin 1 and histatin 3 
Comparison of histatin 3 and histatin 5 
Comparison of histatin 1 and histatin 5 
Comparison between stimulated and unstimulated 
Statistically significant : p < 0.01 
Table 1 O: Concentrations of histatin in relation to total salivary protein in 
submandibular/sublingual secretion.* 
Total Protein_ Histatin 1 Histatin 3 Histatin 5 
Samples (mg%) 
Stimulated 375.9 ± 103.9 
Unstimulated 240.3 ± 48.8 
• 
•• 
Mean from 19 donors . 
Determined by BCA assay. 
2.31 
1.39 
(% of Total Protein) 
1.76 2.73 
0.52 0.97 
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The histatin concentration in relation to total salivary protein is given 
in Table 10. Under stimulated conditions histatin 1, 3, and 5 constituted 
2.31 %, 1.76% and 2.73%, respectively, of the total protein whereas under 
unstimulated conditions, the corresponding values were 1.39%, 0.52%, and 
0.97%, respectively. Thus, the major histatins make up approximately 6.8% 
of the total protein in stimulated su bmandibular / su blingual secretion and 
2.88% of the total protein in unstimulated submandibular/sublingual 
secretion. It is interesting that under stimulated conditions the percentage 
of total histatins in relation to total protein in submandibular / sublingual 
secretion is nearly twice as great as that in parotid secretion. On the other 
hand, under unstimulated conditions, the quantity of histatins relative to 
total protein in su bmandibular / su blingual and parotid secretion was nearly 
the same. 
Whole saliva 
Individual and total histatin concentrations in whole saliva are given 
in Table 11. For whole saliva, the concentrations ranged from 0.84-2.73 
mg<>/o (mean = 1.87 ± 0.58) for histatin 1, 0.26-2.25 mg% (mean = 0.84 ± 
0.63) for histatin 3, and 0.21-4.33 mg% (mean= 1.17 ± 1.02) for histatin 5, 
respectively. The highest concentration was observed for histatin 1 followed 
by histatin 5 and then histatin 3. 
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Table 11: Histatin concentrations in whole saliva. 
* * * Histatin 1 a Histatin 3 b Histatin 5 C Total Histatin 
STIMULATED 
Concentration (mg%) 
Mean concentration 1.87 ± 0.58 s 0.84 ± 0.63 s 1.17 ± 1.02 s 3.88 ± 1.97 
Range of samples 0.84 - 2.73 0.26 - 2 .25 0.21 - 4.33 1.36 - 9.08 
n 19 19 19 
* 
a 
b 
C 
s 
Data were obtained by laser densitometer analysis of basic gel electrophoretograms. 
Comparison of histatin 1 and histatin 3 
Comparison of histatin 3 and histatin 5 
Comparison of histatin 1 and histatin 5 
Statistically significant: p < 0.01 
Table 12: Concentrations of histatin in relation to total salivary protein in whole 
saliva.* 
Total Protein -
Samples (mg%) 
Stimulated 246.4 ± 41.0 
* 
** 
Mean from 19 donors. 
Determined by SCA assay. 
Histatin 1 
0.76 
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Histatin 3 Histatin 5 
(% of Total Protein) 
0.34 0.47 
The his ta tin concentration in relation to total salivary protein is 
given in Table 12. Under stimulated conditions, histatin 1, 3, and 5 
constituted 0.76%, 0.34% and 0.47%, respectively. The major histatins 
make up approximately 1.57% of the total protein in stimulated whole 
saliva. It is interesting that the histatin concentration relative to total 
protein in whole saliva is lower than that in parotid secretion by a factor 
of approximately two and lower than that in su bmandibular / su blingual 
secretion by a factor of approximately three. 
Measurement of total histatins by ELISA 
Immunological techniques have been widely used for measurement of 
proteins in biological fluids and tissue extracts. In the present investigation, 
a sandwich ELISA was developed for quantitation of total histatins in 
glandular secretions and whole saliva. The immunological principle 
underlying ELISA is that variable regions of the heavy and light chains of an 
immunoglobulin G (IgG) can recognize either amino acid sequence or 
structural epitopes in a protein. Therefore, either an antigen or an antibody 
can be immobilized on the surface of a well of a microtiter plate, and the 
immobilized protein can be recognized by an antigen or an antibody in a 
solution added to the well. In a direct ELISA, the antigen is immobilized in 
the well, and an ti bodies added to the well recognize and bind to the 
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immobilized antigen. Customarily, a second antibody complexed to an 
enzyme and directed against the first antibody is added, and the resulting 
antigen: lst-antibody:2nd-antibody-enzyme complex is administered a 
colorless chromogen that is converted to a colored dye by the enzyme 
attached to the second antibody. Measurement of dye color is presumably a 
direct measurement of antigen immobilized on the plastic surface initially. 
In a sandwich ELISA, it is desirable to use two different antibodies against 
the same antigen. The first antibody is attached to the surface of the well, 
antigen is added and allowed to bind to the first antibody, and then a 
second antibody is added and allowed to bind to the antigen. Finally, a third 
antibody complexed to an enzyme and directed against the second antibody 
is added, and color development is allowed to occur as described above. 
Parotid secretion 
Total histatin concentrations were measured in a sandwich ELISA in 
the same samples of glandular secretions and whole saliva as those used in 
densitometric analyses described above. The only difference between 
samples examined by ELISA and the densitometric method is that after the 
-collection procedure, the ELISA samples were frozen immediately whereas 
the densitometric samples were dialyzed, lyophilized, and resuspended in 
water. 
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Data obtained by immunological analysis (sandwich ELISA) measured 
total histatin concentrations in parotid secretion (Table 13). Total histatin 
concentrations under stimulated and unstimulated conditions ranged 
between 1.92-15.52 mg% (mean= 6.19 ± 3.3) and 1.93-15.2 mg°/o (mean= 
5.06 ± 3.2), respectively. Total histatin concentrations determined 
immunologically were nearly three-fold lower than those for the sum of 
individual histatins measured densitometrically, under both stimulated and 
unstimulated conditions. 
Submandibular / sublingual secretion 
Data obtained by immunological analysis measured total histatin 
concentrations in submandibular / sublingual secretion (Table 13). Total 
histatin concentrations under stimulated and unstimulated conditions 
ranged between 6.21-17.25 mg% (mean= 10.78 ± 3.27) and 1.17-12.2 mg% 
(mean = 4 .89 ± 3 .34), respectively. Total histatin concentrations measured 
immunologically were nearly two-fold lower under stimulated conditions but 
were nearly equal under unstimulated conditions, when compared to 
concentrations determined by densitometric analysis . 
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Table 13: Concentration of total histatin under stimulated (S) and unstimulated 
(US) conditions in parotid secretion, submandibular/sublingual 
(SM/SL) secretion, and whole saliva as determined by ELISA*. 
Parotid 
SM/SL 
Whole saliva 
s 
us 
s 
us 
s 
Mean concentration 
6.19 ± 3.3 
5.06 ± 3.2 
10.8 ± 3.2 
4.90 ± 3.3 
2.38±1.7 
* Concentrations are expressed as mg% 
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Range of samples 
1.92-15.52 
1.93 -15.20 
6.21 - 17.25 
1.17 -12.20 
0.40- 5.22 
Whole saliva 
Data obtained by immunological analysis measured total histatin 
concentrations in whole saliva under stimulated conditions (Table 13). These 
results showed that total histatin concentrations ranged from 0.4-5.22 mg% 
(mean = 2.38 ± 1.7). As noted above for glandular secretions, total histatin 
concentrations were also nearly two times lower than those determined 
densitometrically under stimulated conditions. 
Avidity of salivary histatin 
In view of the discrepancy between the sum of histatin 1, 3, and 5 
estimated densitometrically and that of total histatins estimated 
immunologically in the sandwich ELISA, the relative avidity of the histatin 1 
antibody for histatin 3 and 5 was determined. Previous studies have shown 
that the epitope recognized by the anti-histatin 1 antibody is found in the 
carboxyl-terminal region of histatin 1 [Saxer et al., 1992]. Since part of this 
region is missing in both histatin 3 and 5, and the amino acid sequence of 
the epitope region of histatin 1 is slightly different in histatin 3 and 5, it was 
anticipated that the immunological quantitation of histatins in glandular 
secretions and whole saliva might yield somewhat lower values. Therefore, 
studies were performed to determine experimentally the relative avidity of 
the anti-histatin 1 antibody preparation for histatin 3 and 5 in order to 
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generate a correction factor that could be used for immunological 
measurement of total histatins in the sandwich ELISA. 
Histatin 1, 3, and 5 standards were isolated from parotid secretion by 
procedures routinely used in our laboratory. A direct ELISA was employed to 
determine the immuno-recognition of the histatin 1 antibody for histatin 3 
and 5. Briefly, histatin standards (10-200 µg) in PBS were applied to wells of 
a microtiter plate, and plates were incubated overnight at 4°C. After 
washing, goat anti-histatin 1 antibody was applied to wells, plates were 
incubated for one hour at 37°C, wells were washed, rabbit anti-goat IgG 
labeled with alkaline phosphatase was added, and plates were again 
incubated for one hour at 37°C. Wells were washed and p-nitrophenyl 
phosphate chromogen was added, and plates were read at 405 nm on a 
Dyna tech plate reader. 
These results show that the extent of histatin 3 and his ta tin 5 
recognition by the anti-histatin 1 antibody was 85. 9% and 48.5%, 
respectively, when recognition of histatin 1 by the antibody was arbitrarily 
set at 100% (Figure 2). This is consistent with the fact that the histatin 1 
epitope is located in the carboxyl-terminal half of the molecule, and this 
region is either missing or somewhat different in histatin 3 and 5 (see Figure 
IA). The relative avidity of the goat anti-histatin 1 antibody for histatin 3 
and 5 was used to calculate a correction factor for use in histatin 
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Figure 2: Relative avidity of goat anti-histatin 1 antibody for salivary histatins . 
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quantitation by the sandwich ELISA. The corrected ELISA values are 
compared with results obtained by densitometric analysis and discussed 
below. 
Comparison of histatin measurements by densitometry and ELISA 
The immunologically derived values for total histatins in glandular 
secretions and whole saliva (Table 13) were significantly lower than the sum 
of the values for histatin 1, 3, and 5 measured densitometrically (Table 7, 9, 
11). At least one reason for this discrepancy is due to the relative avidity of 
the anti-histatin 1 antibody for histatin 3 and 5 (see Figure 2 above). In the 
sandwich ELISA the anti-histatin 1 antibody recognizes histatin 3 with an 
"efficiency" of 85. 9%, and recognizes histatin 5 with an "efficiency" of 
48.5% compared to histatin 1 (immunological reactivity set arbitrarily at 
100%). Therefore, the ELISA values for total histatins in the samples 
analyzed were corrected for relative avidity, and individual histatin 
concentration determined by laser densitometry according to the formula: 
L Individual histatins 1 + 3 + 5(mg%) 
Correction Factor = 
(Histatin 1 x 1.0) + (Histatin 3 x 0.86) + (Histatin 5 x 0.49) 
ELISA c = Correction Factor x ELISA value 
The sum of individual histatins determined densitometrically is 
compared to the raw and corrected ELISA values in Table 14. Even after 
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Table 14: Comparison between densitometry, ELISA, and ELISA c data . 
Parotid 
SM/SL 
Whole saliva 
s 
us 
s 
us 
s 
Densitometry 
17.63 ± 8.00 
17.43 ± 11.96 
25 .55 ± 10.30 
7.16 ± 3.99 
3.88 ± 1.97 
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ELISA 
(mg%) 
6.19 ± 3.3 
5.06 ± 3.2 
10.8±3 .2 
4.9 ± 3.3 
2.38 ± 1.7 
ELISA c 
8.32 ± 4.4 
7.28 ± 4.9 
14.1 ± 4.0 
5.9 ± 3.9 
2.9 ± 2.43 
the ELISA values were corrected according to the formula shown above, 
they are still substantially lower than the histatin values determined 
densitometrically. As a first approximation, the corrected ELISA 
measurement of total histatins underestimated the concentration by a factor 
of approximately two in stimulated and unstimulated parotid secretion and 
in stimulated submandibular/sublingual secretion (Figure 3). The ELISA 
and densitometric measurements of total histatins in unstimulated 
submandibular/sublingual secretion and stimulated whole saliva were in 
much better agreement. 
Salivary histatin output 
The secretory rate of a protein can be expressed by a parameter called 
"output" which is calculated by multiplying the flow rate in ml/min times 
the protein concentration in mg/ml. Output defines the capacity of a gland 
to synthesize and secrete a certain quantity of a protein as a function of 
time. Salivary histatin output was calculated from the mean values of the 
flow rate, total protein concentrations (Table 6), and total histatin 
concentrations based on densitometric analysis (Table 7 and 9). 
Histatin output by parotid and submandibular/sublingual glands 
under stimulated and unstimulated conditions is shown in Figure 4. First, 
total protein output was 17 times greater in parotid gland ( 10.3 versus 0.6 
mg/min) and 6.6 times greater in submandibular/sublingual gland (8.35 
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Figure 3: Total histatin concentrations in parotid secretion, submandibular/sublingual secretion, 
and whole saliva under stimulated and unstimulated conditions determined by 
densitometric analysis (solid bar) and ELISA (hatched bar). The ELISA values were 
corrected for differential avidity of the histatin 1 antibody for histatin 3 and histatin 5. 
Abbreviations: PS, parotid stimulated; PU, parotid unstimulated; SS, 
submandibular/sublingual stimulated; SU, submandibular/sublingual unstimulated; 
and WS, whole saliva. 
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Figure 4: Comparison of total protein output (solid bar) with total histatin output (hatched bar) 
from both pairs of parotid and submandibular/sublingual glands. Numbers over the 
bars represent output values (mg/min) under stimulated and unstimulated conditions. 
Output (mg/min) = Flow Rate (ml/min) x Concentration (mg/ml). Since output is a 
calculated value based on the product of mean flow rates and protein concentrations, 
error bars are not included on this bar graph. 
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versus 1.27 mg/min) under stimulated conditions compared to 
unstimulated conditions. Second, total histatin output was 22.5 times 
greater in parotid gland (0.45 versus 0.02 mg/min) under stimulated 
conditions compared to unstimulated conditions. Total histatin output was 
14.3 times greater in submandibular/sublingual gland (0.57 versus 0.04 
mg/min) under stimulated compared to unstimulated conditions. Third, 
total histatin output represents 4.4% (0.45/ 10.3 x 100) and 3.3% (0.02/0.6 
x 100) of total protein in stimulated and unstimulated parotid secretion, 
respectively; total histatin output represents 6.8% (0.57 /8.35 x 100) and 
3.2% (0.04 / 1.27 x 100) of total protein in stimulated and unstimulated 
submandibular / sublingual secretion, respectively. Finally, histatin output 
in submandibular/sublingual secretion was 26% (0.57 /0.45 x 100) higher 
under stimulated conditions, and 50% (0.04 /0.02 x 100) higher under 
unstimulated conditions than in parotid secretion. 
Survival of histatin in whole saliva 
It is generally recognized that on a volume basis, whole saliva is 
derived in large part from parotid and su bmandibular / su blingual secretions 
with a relatively small (< 15%) contribution from minor salivary glands and 
gingival crevicular fluid. Therefore, if the volume of whole saliva comes from 
nearly equal contributions from the major salivary glands, one might predict 
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that the concentration of histatins in whole saliva should be comparable to 
that in glandular secretions. In fact, comparison of the concentrations of 
total histatins in glandular secretions (Table 7, 9) with that in whole saliva 
(Table 11) revealed a surprisingly large discrepancy in the predicted 
concentration of histatins in whole saliva. In fact, total histatins were 5 fold 
lower in whole saliva that in glandular secretions. 
Since it is also well known that whole saliva contains a host of 
proteolytic enzymes derived in large part from oral microbes, a series of 
experiments was conducted to determine whether the low histatin levels 
found in whole saliva could be explained on the basis of proteolysis. This 
was accomplished by measuring the survival of histatin 3 after addition to 
whole saliva before and after boiling in order to inactivate proteases. Control 
experiments were performed where histatin 3 samples were incubated at 
room temperature or 100°C for 3 min, filtered through a 10,000 molecular 
weight cut-off filter, and the filtrate was subjected to RP-HPLC. When 
histatin 3 controls were treated in this way no significant losses of protein 
were observed either as a result of boiling or filtration (Figure 5, bar 1, 2). 
Next, histatin 3 was added to boiled whole saliva and examined by RP-HPLC 
immediately or after incubation at 37°C for 20 min. Under both treatments 
there was a 70% reduction in the chromatographically detectable histatin 3 
(Figure 5, bar 3, 4). This striking loss of histatin 3 can not be explained by 
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Figure 5: Survival of exogenous histatin added to whole saliva supernatant. For control, histatin 
3 was incubated at 20°c (bar 1) or 100°c (bar 2) for 3 min, filtered and quantitated by 
HPLC. For experimental samples, histatin 3 was added to boiled WS and incubated at 
37°c for 0 min (bar 3) or 20 min (bar 4). Histatin 3 was also added to non-boiled WS 
and incubated at 37°C for 0 min (bar 5), 1 min (bar 6), 5 min (bar 7) and 20 min (bar 
8). This experiment was carried out on numerous occasions with different samples of 
whole saliva and the values shown above are those from a representative experiment. 
86 
proteolytic degradation because the whole saliva samples had been boiled to 
inactivate proteases prior to incubation. Finally, when histatin 3 was added 
to unboiled whole saliva, the quantity of histatin 3 remaining steadily 
declined from 30% to 10% over a 20 min period (Figure 5, bar 6-9). These 
losses most likely result from degradation of histatin 3 by proteases, but the 
magnitude of proteolytic losses were minute compared to those obsetved by 
simple addition of histatin 3 to boiled whole saliva (Figure 5, bar 3, 4). This 
decrease can possibly be explained by the formation of heterotypic 
complexes between histatin 3 and other salivary proteins. 
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DISCUSSION 
The oral cavity is an ecological environment which requires a 
continuous equilibrium between its various components in order to 
preserve oral health. Saliva, which is the most important factor 
responsible in the protection of hard and soft tissues in the oral cavity, 
carries out its essential protective role due to its numerous components. 
Salivary proteins constitute a large percentage of the macromolecules in 
salivary secretions, and these proteins exhibit multiple functions which 
collectively contribute to both the immune and non-immune host defense 
system in the oral cavity. Therefore, determination of the physiological 
concentration of salivary proteins is of considerable scientific interest 
because knowledge of the concentration of a protein in a biological fluid 
will enhance understanding of the concentration-function relationships. 
Many investigators have focused their research on characterization 
of the biological properties of salivary proteins in functional assays in 
vitro. Consequently, it is essential to determine the range of physiological 
concentrations of proteins in glandular secretions and whole saliva 
under stimulated and unstimulated conditions in order to know whether 
the salivary protein host defense functions measured in vitro have 
biological relevance. Since histatins are known to be key players in the 
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non-immune oral defense system, the present investigation focused on 
determining the physiological range of histatin concentrations in parotid 
secretion, submandibular / sublingual secretion, and whole saliva. 
Quantitative measurement of proteins which occur as families in 
biological fluids presents special challenges because not only is it 
necessary to separate the proteins of interest from all other components, 
but it is also necessary to separate individual family members from one 
another. Histatins may perhaps represent a particularly difficult case 
with respect to quantitation because (a) the major histatins constitute 
70-80% of the family, and the minor histatins constitute 20-30% of the 
family; (b) the major histatins are similar in size; (c) the primary 
structure of histatin 1 and 3 are 94% identical; and (d) histatin 5 is 
derived proteolytically from histatin 3, and hence the first 24 residues of 
histatin 5 are identical to those in histatin 3. In view of the above, the 
first analytical procedure selected for measurement of histatins in 
glandular secretion and whole saliva was densitometric analysis of 
histatins separated by the cationic PAGE system described by Baum et 
al. [1977a]. This electrophoretic system is advantageous as it completely 
separates the cathodically migrating major histatins from the minor 
histatins and from all other proteins in glandular secretion and whole 
saliva. 
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The second analytical procedure selected for measurements of 
histatins was a sandwich ELISA. The advantage of sandwich ELISAs over 
direct ELISAs is that quantitation is potentially more sensitive and more 
accurate. This is because in a direct ELISA the blocking step after addition 
of the antigen to the well could partially mask entire antigen molecules or 
antigenic sites. In contrast, in a sandwich ELISA, the first antibody is first 
added to the well in excess and, therefore, is theoretically capable of 
recognizing and binding all added antigen which should result in more 
accurate immunological quantitation. 
Some advantages of the ELISA procedure are that (a) reproducible 
and very sensitive quantitation can be achieved if good immunological 
reagents are available, (b) histatin concentrations can be determined on a 
large number of samples in a single microtiter plate, (c) assays can be 
carried out in a relatively short time, and (d) it should be possible to 
quantify all of the major (and perhaps some minor ?) histatins in a single 
immunological measurement. On the other hand, the ELISA measures total 
histatins. One could envision that the densitometric method described 
above might be preferable under certain circumstances where it is 
important to know the concentration of each individual histatin. 
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Flow rate 
Flow rate is an important physiological parameter which is 
essential to the maintenance of a healthy oral environment. Flow rate is 
important because of its influence on (a) protective functions with respect 
to lubrication, mastication, clearance of oral microbes, buffering and 
remineralization; (b) food-related functions such as taste, food 
preparation, and digestion; and (c) speech-related functions. In addition, 
flow rate is probably the single most important factor that affects the 
protein and electrolyte composition of saliva. 
When salivary flow is significantly decreased this leads to the 
condition of "dry mouth" known as the sensation of xerostomia [Edgar 
and O'Mullane, 1996). In view of the many biological functions of saliva 
mentioned above, it is clear that xerostomia has far reaching 
implications. The clinically associated manifestations of xerostomia can 
lead to even broader social problems ranging from impaired 
communication, loss of appetite, and difficulty in swallowing, eating, 
tasting, and wearing dentures. It is noteworthy that decreased salivary 
flow rate can be caused by over 400 commonly-used drugs, therapeutic 
irradiation, systemic diseases such as hormonal disorders (e.g., diabetes 
mellitus), and neurological disorders (e.g., Parkinson's disease). In 
addition, decreased salivary flow rate is seen in dysfunction of the 
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immune system (e.g., AIDS), rheumatoid conditions (e.g., Sjorgen's 
Syndrome), psychogenic disorders (e.g., depression) and aging [Sreebny 
et al., 1992]. 
Mean flow rates for glandular secretions measured in this study 
were in general agreement with those reported in the literature (Table 2). 
The only exception found was for stimulated submandibular/sublingual 
secretion, where our values were about two times higher than those 
reported by other investigators. The higher values obtained are consistent 
with the "self-stimulatory" effect of the collecting device placed in the 
su blingual space to harvest the secretion. 
In the present work, the mean flow rate of parotid secretion was 
2.56 ± 1. 15 ml/min whereas the mean flow rate of 
submandibular/sublingual secretion was 2.22 ± 0.98 ml/min, under 
stimulated conditions. It is interesting to note that these stimulated flow 
rates are high and nearly identical. In a normal adult human, the best 
evidence indicates that the average weight of a parotid gland ranges from 
15-30 g, that of a su bmandibular gland ranges from 4-10 g, and that of a 
sublingual gland ranges from 2-3 g [T. Xu, personal communication]. It is 
generally accepted that both pairs of parotid glands and both pairs of 
su bmandibular / su blingual glands make approximately equal 
contributions to the volume of whole saliva, and that minor salivary 
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glands and gingival crevicular fluid contribute less than 10% of the 
volume of whole saliva. Therefore, since the parotid glands are 2-2.5 
times larger than the su bmandibular / su blingual glands, and since these 
pairs contribute equally to the total volume of whole saliva, either the 
secretory capacity of the su bmandibular / su blingual glands must be 
approximately 2.0-2.5 times greater or in parotid glands, water 
absorption by cells lining the striated and intercalated ducts is more 
efficient. 
Relationship between flow rate and protein concentration 
There is an interesting relationship between the effect of flow rate and 
the duration of stimulation on the concentration of protein in salivary 
secretions. This phenomenon is physiologically distinct in parotid and 
submandibular / sublingual glands as illustrated in Figure 6. For parotid 
secretion, the protein concentration falls immediately after application of a 
stimulus, and with continued stimulation, the protein concentration soon 
begins to rise and eventually reaches a higher concentration than initially 
present (Figure 6A). The magnitude of the increase in protein concentration 
is strongly dependent on the flow rate and the duration of stimulation. In 
the example shown in Figure 6A, the protein concentration is 
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Figure 6: The relationship between the effect of flow rate and duration of stimulation on the 
protein concentration in human parotid secretion (A) and submandibular/sublingual 
secretion (8). Adapted from the data of Dawes (1969 and 1971]. 
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two to three times greater at high flow rates than at low flow rates after 
stimulation for 30 min. 
The behavior of su bmandibular / su blingual glands in response to 
application of a stimulus is quite different (Figure 6B). There is no fall in the 
protein concentration immediately after application of a stimulus, and with 
continued stimulation, the protein concentration increases to a maximum 
and then levels off. The maximum protein concentration attained is 
dependent on the flow rate and duration of stimulation with the highest 
protein concentrations found at the highest flow rates. In the example 
shown in Figure 6B, the protein concentration is about 2 times greater at 
high flow rates than at low flow rates after stimulation for 30 min. 
The different responses of the major salivary glands with respect to 
protein concentration following a stimulus seems to be contradictory in view 
of the relative sizes of these glands. Since the size of the parotid glands is 
more than two times greater than that of the combined 
su bmandibular / su blingual glands, one might predict that the flow rate of 
the parotid gland might be two times larger. However, this is not the case 
because in the present investigation the stimulated flow rates of parotid and 
submandibular / sublingual glands were nearly equal. As mentioned above, 
this could be explained on the basis of the differential rates of water 
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absorption in glandular ducts or the relative number and complexity of acini 
in parotid and submandibular/sublingual glands. 
Protein concentration 
It is known that the results obtained for measurement of total protein 
in saliva depends not only on the method used [Wolf and Taylor, 1964] but 
also on the standard protein employed [Dawes, 1965]. This makes it difficult 
to compare the values of total protein concentration in the present work 
(Table 6) with the values reported in the literature (Table 1). In our study, we 
estimated the concentration of total salivary protein by method of Lowiy et 
al. [1951] with bovine serum albumin (BSA) as standard, where color 
development in protein solutions depends both on the number of peptide 
bonds and the tyrosine, tiyptophan, cysteine, and cystine content of the 
proteins [Wiechelman et al., 1988]. Strictly speaking, it is recognized that, 
the most accurate method of determining protein concentration in a 
biological fluid is quantitative amino acid analysis. Due to the large number 
of samples in the present investigation it was not feasible to use amino acid 
analysis for protein quantitation. 
The concentration of total protein in unstimulated parotid secretion 
was more than 2 times greater than that of unstimulated 
submandibular/sublingual secretion (Table 6). This is in excellent 
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agreement with the pattern of total protein in unstimulated parotid 
secretion from a smaller number of subjects described by Dawes [1969, 
1971]. However, under stimulated conditions the total protein concentration 
in parotid and su bmandibular / su blingual secretions was nearly equal. This 
is not unexpected because samples were collected at high flow rates where 
one would expect the protein concentrations to be high and approaching the 
maximum value (see Figure 6). It is generally accepted that whole saliva is 
derived from approximately equal contributions of secretions from the 
parotid and su bmandibular / su blingual glands. Since the protein 
concentration in secretions from these glands is about equal, one would 
expect to find a similar protein concentration in whole saliva. However, it is 
known that the protein concentration in glandular secretions is affected by 
the nature of the stimulus, and that lower protein concentrations are 
observed with mechanical stimulation as opposed to gustatory stimulation 
[Dawes, 1988]. The use of mechanical stimulation during collection of whole 
saliva in these studies is probably the major reason for the discrepancy 
between total protein concentrations in glandular secretions and whole 
saliva. 
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Densitometric measurement of the concentration of individual 
histatins. 
Two methods were used to measure histatins in glandular 
secretions and whole saliva. Densitometric analysis showed that the 
concentration of histatin 1, 3, and 5 in glandular secretions under 
unstimulated conditions ranged from 1.26-9.39 mg% (Table 7, 9) and 
under stimulated conditions, ranged from 4.64-10.25 mg% (Table 7, 9). 
This broad range of histatin concentrations is not surprising because of 
the wide variability in the concentration of other salivary proteins 
measured previously by other investigators under different physiological 
conditions. Except for histatin 1 in parotid secretion, there was a 
statistically significant increase in the concentration of total and 
individual histatins in glandular secretions under stimulated conditions. 
The general pattern that emerges from these measurements is that 
histatin 5 displayed the statistically highest concentration in both 
stimulated and unstimulated glandular secretion. The exception was 
unstimulated submandibular / sublingual and stimulated whole saliva, 
where histatin 1 was the most elevated. 
Total and individual histatin concentrations in whole saliva were 
statistically lower than that of glandular secretion. This was not 
unexpected due to the proteolytic action of enzymes present in whole 
saliva and complexing of histatins with other salivary components 
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[Oppenheim et al., 1996]. Histatins appear to arise by a series of highly 
specific proteolytic processing events. With the exception of histatin 2, 
which is a proteolytic fragment of histatin 1, all other histatins could be 
derived by tryptic-like or chymotryptic-like cleavages of his ta tin 3. This 
might explain why histatin 3 tented to displaye the lowest concentration 
in glandular secretion and whole saliva . 
One of the significant findings of the research presented in this 
dissertation is that the measured concentration of histatins in glandular 
secretions and whole saliva are in the range to exhibit a broad spectrum 
of antimicrobial activities in the oral cavity (Table 15). For example, the 
mean concentrations of histatin 1, 3, and 5 are well within the range of 
the LD50 for killing C. albicans blastospore and germinated cells and the 
1D50 for inhibition of C. albicans germination [Xu et al., 1991]. It is also 
significant that the mean concentration of histatins are within the range 
required for other antimicrobial activities including growth inhibition of 
the mutans group of Streptococci [MacKay et al., 1984; Xu and 
Oppenheim, 1990], growth inhibition of certain periodontal pathogens 
[Xu and Oppenheim, 1990], inhibition of bacterial proteases [Lamkin et 
al., 1993], and inhibition of hemagglutination of oral bacteria [Kalpidis et 
al., 1995]. 
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Table 15: Concentration-Function relationship of salivary histatins. 
Histatin 1 Histatin 3 Histatin 5 
Concentration range (mg%) 0.84 -16.1 0.20 -13.88 0.21 -21.8 
LDso (mg%) 
C. albicans 
yeast form 3.1 1.7 0.6 
mycelial form 35.2 4.6 2.9 
Mutans of streptococci 
S. mutans 20.9 6.4 2.7 
S. rattus 23.7 6.5 2.8 
S.sobrinus 33.2 10.1 4.7 
Periodontal pathogens 
P. gingivalis N.D. N.D. 155 
B. forsythus N.D. N.D. 150 
P. intermedia N.D. N.D. 150 
F. nucleatum N.D. N.D. 150 
P. micro N.D. N.D. 225 
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Immunological measurement of the concentration of individual 
histatins 
The second method used to measure histatins in glandular 
·secretions and whole saliva was a sandwich ELISA. This procedure 
estimates the total histatin concentration in contrast to the densitometric 
method which individually measures the major histatins 1, 3, and 5, as 
discussed above. The sandwich ELISA values for total histatins in 
glandular secretions, even after correction for avidity (see Figure 2), were 
almost two times lower than the sum of histatin 1, 3, and 5 determined 
densitometrically (see Table 14). The complete explanation for this 
discrepancy is not certain but some of the possibilities are briefly 
discussed below. First, the lower values observed in immunological 
quantitation can be explained in part by the structural differences 
between histatin 1, 3, and 5, and the properties of the primary and 
secondary antibodies used. The primary antibody used to coat wells in 
microtiter plates was a rabbit polyclonal antiserum directed against a 
peptide with a sequence identical to residue 12-24 of histatin 3. 
Inspection of the primary structures of histatins (see Figure 1) reveals 
that histatins 1 and 3 are different at residue 23 and 24. In histatin 1 
Glu and Phe occur at these positions, whereas in histatin 3 and 5 Gly 
and Tyr occur at these positions. Since the rabbit polyclonal antiserum 
against residue 12-24 of histatin 3 was the primary antibody in the 
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sandwich ELISA, it is possible that this antibody preparation bound 
histatin 1 somewhat less effectively than histatin 3, resulting in an 
underestimation of total histatins. The polyclonal rabbit antibody 
directed against residue 12-24 of histatin 3 would be expected to react 
comparably with histatin 5 because residue 12-24 of histatin 3 and 5 are 
identical. 
Second, when the polyclonal goat anti-histatin 1 antiserum used as 
the second antibody was characterized in a direct ELISA, it was found that if 
the reactivity of histatin 1 was set at 100%, peptides corresponding to the 
N-terminal, middle, and carboxyl-terminal regions of histatin 1 showed that 
this antiserum exhibited: the greatest affinity for the carboxyl-terminal third 
(equivalent to 34 % of that of histatin 1), less specificity for the middle third 
(7 .5 % of that of histatin 1), and no specificity for the amino terminal third 
of histatin 1 [Saxer et al., 1992]. One interpretation of these results is that 
the epitope or epitopes recognized by this polyclonal antiserum are located 
primarily in the carboxyl-terminal third of histatin 1 but span the junction 
between the middle and carboxyl-terminal regions. This premise was 
confirmed by showing that the avidity of this antibody preparation for 
histatin 3 was 86%, and for histatin 5 was 49%, when compared to histatin 
1 which was arbitrarily set at 100% (see Figure 2). It may seem unusual 
that in reference to histatin 1 ( 100% reactivity), the goat anti-histatin 1 
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antibody preparation displayed 34% activity with the peptide corresponding 
to residue 25-38 of histatin 1 and 49% with histatin 5 (lacking residues 25-
32 of histatin 3 and residues 25-38 of histatin 1). These data strongly 
suggest that this antibody preparation recognizes one or more structural 
epitopes in histatin 1 that are absent in histatin 3 and histatin 5. Although 
the avidity studies are in general agreement with the immunoreactivities of 
the histatin 1 peptides [Saxer et al., 1992] they show that it is difficult to 
generate an antibody preparation (or two antibody preparations for a 
sandwich ELISA) that will react equally with each of the major histatins. 
Third, despite correcting the raw ELISA values for relative avidity of 
the anti-histatin 1 antibody preparation the corrected ELISA values were 
still too low by a factor of nearly two. A likely explanation for this is that 
histatins form complexes with other proteins in saliva, and complexing may 
mask or partially hinder recognition of the histatin epitopes. As discussed 
below, histatin 3 complexes with other proteins in whole saliva (see Figure 
5), and it has recently been shown that histatins in 
submandibular/sublingual secretions form heterotypic complexes with the 
high molecular weight salivary mucin, MG 1 [Iontcheva et al., 1996]. 
As discussed above, it has been shown that the histatin levels in 
glandular secretions and whole saliva measured in the sandwich ELISA, 
even after correction for antibody avidity, were approximately one half those 
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determined by the densitometric method. Assuming that the densitometric 
method accurately measures the levels of the major histatins, this 
procedure has considerable potential value for investigating the role of the 
non-immune oral host defense system in certain clinical situations. For 
example, the same goat anti-histatin 1 used in this work was also used in a 
competitive ELISA to measure total histatins in both stimulated and 
unstimulated parotid and submandibular / sublingual secretions in patients 
infected with HIV-1 [Atkinson et al., 1990]. These investigators found that 
histatin concentrations were elevated in HIV-1 positive individuals when 
compared to age-matched healthy volunteers at low risk for HIV infection. 
This suggests that the non-immune oral defense system might partially 
compensate for a compromised immune system in HIV-1 infected 
individuals. In another study at a different institution, no significant 
differences were seen in histatin levels in stimulated parotid secretion in 
HIV-1 infected individuals when histatins were measured by rocket 
electrophoresis [Mandel. et al., 1992]. In yet another study, a significant 
decrease in histatin levels in stimulated parotid and 
su bmandibular / su blingual secretion was observed in HIV-1 infected 
individuals compared with healthy adult controls when histatins were 
measured by capillary electrophoresis [Lal et al., 1992b]. These results 
suggested that both the immune and non-immune defense systems are 
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compromised in HIV-1 infected individuals. The conflicting results from each 
of the above clinical studies points out the need for a reliable and accurate 
method for measurement of the true concentration of histatins in salivary 
secretions. Based on the results described in this dissertation, it would 
appear that the densitometric method would be more suitable for accurate 
measurement of histatins in glandular secretions and whole saliva, and that 
this methodology could be used to reinvestigate the question of whether 
histatin levels are altered by HIV-1 infection. The densitometric method for 
histatin quantitation could also be used to evaluate other clinical situations 
leading to altered health such as candidiasis, caries, and periodontal 
disease . 
Salivary histatin output 
Output is a physiological parameter which describes the capacity of a 
gland to secrete a protein as a function of time and concentration. In the 
present work, the values for output were determined by multiplying the 
mean flow rate in ml/min times the mean concentration in mg/ 100 ml. The 
sum of the concentrations of histatin 1, 3, and 5, determined 
densitometrically, were used to calculate output values (see Figure 4). Total 
histatin output was shown to increase with stimulation in both parotid and 
submandibular / sublingual secretion. That is, the quantity of histatins 
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produced per unit time increases substantially with an increase in flow rate, 
consistent with the results of Jensen et al. [1994]. For example, parotid 
glands produce more than 20 times more histatins under stimulated 
conditions than under unstimulated conditions; similar increases also occur 
in submandibular/sublingual glands. If the in vitro antimicrobial properties 
of histatins are an accurate reflection of events in vivo, the large capacity to 
produce histatins at higher flow rates could generate a remarkably effective 
non-immune host defense against a wide variety of oral microbes. This 
histatin-producing capacity may be an evolutionary adaptation in old world 
monkeys and early human species to maintain oral health in the absence of 
modem day oral hygiene (tooth brushing, prophylaxis, etc.). Alternatively, 
the ability of the major salivary glands to greatly increase histatin output 
may be the consequence of the more general need to rapidly produce saliva 
to enhance mastication, swallowing, and speech. 
The values for total histatin output in relation to total protein in 
stimulated parotid (two glands) secretion and stimulated 
submandibular/sublingual secretion were similar (i.e., 4.4% and 6.8%, 
respectively). The corresponding values for unstimulated parotid secretion 
and submandibular/sublingual secretion were nearly identical (i.e., 3.3% 
and 3.2%, respectively). These values show that parotid and 
submandibular/sublingual glands contribute about equally to the 
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production of histatins under both stimulated and unstimulated conditions, 
but under stimulated conditions, histatins comprise a somewhat higher 
percentage of the total protein. 
Survival of histatins 
Proteins in a biological fluid such as serum, cerebral spinal fluid, or 
glandular secretions of the oral cavity, gastrointestinal tract, or respiratory 
tree, could exist in solution as the free macromolecule, as homodimers or 
homomultimers, or as heterotypic complexes with one or more other 
proteins. Little is known about complexing between the various proteins 
found in secretions from the major salivary glands and whole saliva. A 
surprising result in the present investigation was the observation that when 
synthetic histatin 3 was added to whole saliva, approximately 70% became 
complexed with salivary proteins and only 30% was present unbound (see 
Figure 5). When the 30% of histatin 3 that did not bind was incubated with 
unboiled whole saliva over a 20 min period, the recoverable histatin 3 
declined to 10% of that initially present. Thus, loss of histatins in the oral 
cavity due to proteolysis is a relatively minor factor, and complexing with 
other salivary proteins is a major factor, controlling the survival and 
concentration of histatins in whole saliva. 
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The fact that histatins complex with other proteins may provide an 
explanation for the lower histatin values obtained with the sandwich ELISA 
compared to the densitometric method. In the sandwich ELISA, histatins 
bound to other salivary proteins may not react with the immunological 
reagents as effectively as purified histatins used as standards. In contrast, 
under the conditions of cationic PAGE, histatins are separated from all other 
proteins and the individual histatins can be estimated densitometrically by 
reference to purified histatin standard run on the same gel. 
Since exogenous histatin 3 added to whole saliva appears to exist 
mostly as complexes with other salivary proteins, it is reasonable to assume 
that the endogenous histatins are also largely complexed to salivary 
proteins. The question arises as to whether histatins complexed to other 
proteins exhibit the same antimicrobial activities. It is possible that the LD50 
and ID50 values of histatins complexed to other proteins might be very 
different than those of purified histatins used in antimicrobial assays. It 
would be of considerable interest in the future to determine the specific 
proteins to which histatins become attached, to determine the histatin 
binding domains on these proteins, and to measure the stoichiometry of 
histatin: protein complexes in glandular secretions and whole saliva. 
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Histatins and periodontal disease 
Gingivitis is a mild inflammation of the gingiva caused by 
accumulation of the microbial plaque on tooth surfaces. A qualitative 
and/ or quantitative shift in the microbial plaque can lead to the initiation 
and the progression of periodontitis. Periodontal diseases are pathological 
conditions that affect the supporting tissues of the teeth such as periodontal 
ligament, cement, and bone. Periodontitis involves loss of connective 
tissue attachment to root surfaces in the presence of gingival 
inflammation which can lead to tooth loss. 
Histatins might play a role in periodontitis due to their antimicrobial 
activities. These include agglutination of P. gi,ngivalis [Murakami et al., 
1990], inhibition of a protease secreted by P. gi,ngivalis [Nishikata et al., 
1991), and inhibition of A actirwmycetemcomitans leukotoxin by preventing 
it from binding to human PMNs [Murakami et al., 1995]. 
Since B. gi,ngivalis and A. actirwmycetemcomitans has been strongly 
implicated in tissue destruction in periodontal disease, histatins may play 
an important role as a host-derived defense against periodontal disease. 
Though histatins may prevent periodontitis by maintaining a normal 
ecological microflora, they probably do not play a significant role in arresting 
periodontal diseases due to the lack of accessibility of whole saliva 
(including histatins)into the deep pockets and surrounding tissue. On the 
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other hand, histatins, may have a role in the early stages of gingivitis by 
their action on periodontal pathogens located on exposed tooth surfaces 
prior to their deep infiltration into the periodontal pockets. 
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CONCLUSION 
The purpose of this study was to determine the physiological 
concentration of the three major histatins, histatin 1, 3, and 5, in 
glandular secretions and whole saliva and to understand their 
concentration-function relationship. In addition, the rate of histatin 
production under stimulated and unstimulated conditions as well as the 
survival and clearance of histatins from the oral cavity was explored. 
Densitometric and immunologic analysis revealed that there was a 
high degree of variation in the concentration of histatin 1, 3, and 5 in our 
cohort of 19 healthy individuals. Stimulation with citric acid (i.e., sour 
lemon drops) was shown to enhance the concentration of all major 
histatins in glandular secretions, and the greatest stimulation was 
observed in su bmandibular / su blingual secretion. 
A new finding in this work was that complexing of histatins with 
other salivary components was the major factor in the lower 
concentrations of histatins found in whole saliva. In contrast to 
complexing, enzymes which are responsible for the proteolytic degradation 
of histatins appear to play only a relatively minor role in modulating histatin 
concentrations in the oral cavity. 
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Histatins are multifunctional proteins that provide protection to 
hard and soft tissues in the oral cavity. These proteins exhibit important 
biological activities including: (a) bactericidal and bacteriostatic effects 
against several strains of the mutans group of Streptococci; (b) antifungal 
effects against the pathogenic yeast, C. albicans, such as killing of 
blastospores, killing of germinated cells, and inhibition of germination; and 
(c) regulatory effects on the mineral-solute dynamics by inhibiting 
precipitation of calcium phosphate from supersaturated solutions (e.g., 
whole saliva) thereby providing protection to enamel surfaces. 
The concentration of major histatins required to achieve the above 
mentioned host defense functions was well within the experimentally 
determined range in most of the donors. Studies which further define the 
functional domains for optimal biological activity of histatins will provide the 
data base for development of artificial salivas and mouthwashes. The 
technology exists for inexpensive production of short polypeptides on a large 
scale, and use of functional domains for the various biological activities of 
histatins to generate potentially useful therapeutic agents is well within the 
realm of reality. A great advantage of histatins is that they are naturally 
occurring proteins synthesized in human salivary glands, and as 
components of the oral host defense system, they are not likely to be toxic or 
immunogenic. The multifunctional capacity and potential of this family of 
112 
salivruy proteins indicates a promising future for use of histatins or histatin 
functional domains as supplements in toothpaste and mouthwash in order 
to prevent the development of periodontal disease and caries. 
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